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Abstract 
Activation induced cytidine deaminase (AID) is a 198 amino acid DNA 
mutating enzyme that converts deoxycytidine (dC) to deoxyuridine (dU) in single-
stranded DNA (ssDNA). AID activity is important for adaptive immune responses 
with a key role during the affinity maturation of antibodies in activated B-
lymphocytes. AID targets the trinucleotide motifWRC (W=A/T, R=A/G) on (ssDNA), 
but neither its enzymatic mechanism(s) nor its modes of binding to ssDNA are 
known, largely due to a lack of protein structural information. A model of the 
enzymatic structure of AID suggested two potential ssDNA binding grooves on its 
surface. To confirm or refute the presence of two substrate binding grooves (Groove 
1 and 2); amino acid residues were mutated singly or in combination in Grooves 1 
and 2 to evaluate changes in DNA binding affinities and AID enzyme activity velocity 
compared to wild-type (wt) protein. Some AID mutants were inactive and had little 
or no binding to DNA, while others retained these properties relative to the wt 
enzyme. Contrary to our hypothesis, electrostatic interaction is not integral to AID 
and substrate interaction as previously believed. Along with activity and binding, 
conformational changes were confirmed in AID mutants, which could explain the 
differences in enzymatic functionality. Our research suggests AID conformation is 
key for substrate targeting and binding, and that putative Groove 1 likely contains 
contact points with ssDNA substrate. 
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Chapter 1 Introduction 
1.1 The Immune system and development of the antibody response 
The human immune system is comprised of two main types of defence 
against pathogens: innate responses and adaptive responses. The innate immune 
response is a first line of defence that is constitutively present and consists of 
physical barriers, chemicals, and cells (e.g. macro phages) that non -specifically block, 
take up, and degrade invading agents. Meanwhile, the adaptive immune response 
takes days to weeks to develop after a pathogenic invasion, but is highly antigen 
specific, ensuring the generation and maintenance of immunological memory for 
subsequent challenges. The adaptive immune response is largely carried out by cells 
known as lymphocytes, of which there are two types: B cells and T cells (Fleisher et 
al., 1997; Lanasa et al., 2011; Warrington et al., 2011). 
B cells are integral to adaptive immunity, in that they specifically bind a wide 
variety of pathogens through their surface-expressed antibodies. The initial 
antibody repertoire of B cells covers a wide range of antigens with low affinity, since 
it has not yet encountered any specific antigen. Such B-cells are considered naive B-
cells and originate in bone marrow, a primary lymphoid organ (Gellert, 2002). 
Immunoglobulins or antibodies are first expressed on the membrane surface of the 
B-cell as a B-cell receptor (BCR) and then interact with antigens. Pathogens are 
capable of activating B cells by crosslinking Ig (immunoglobulin) M-type antibodies 
on the B cell surface. The B cell then releases soluble antibodies that specifically bind 
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antigens, before migrating to secondary lymphoid organs, lymph nodes, to form 
germinal centres. Within the germinal centres, B-cells mature in a process known as 
affinity maturation, undergoing proliferation and activation-induced cytidine 
deaminase (AID)-mediated mutagenesis of antibody genes (Fleisher et al., 1997; 
Lanasa et al., 2011; Warrington et al., 2011). During this process, B cells develop 
antibodies with higher affinity for specific antigens thereby eliciting a stronger and 
more specific immune response against the current infection and against any future 
infection by the same pathogen (Martinet al., 2002; Muramatsu, et al., 2000 Okazaki 
et al., 2002; Revy, et al., 2000). In addition to higher affinity, gene rearrangement can 
also occur causing B cells to switch different antibody isotypes (lgA, IgE, and IgG), 
which ultimately determines functionality. Some of these B cells will become 
antibody secreting plasma cells, while others differentiate into memory cells, 
retaining a strong affinity for the specific pathogen encountered. This ensures a 
more efficient immune response during subsequent infection by the same pathogen 
(Longerich et al., 2006). 
1.2 Antibody structure, primary and secondary antibody diversification 
The structure of an antibody molecule is loosely "Y" shaped (Fig. 1) and is 
comprised of 2 heavy chains and 2 light chains held together by disulphide bonds. 
Heavy chains are composed of constant and variable regions, with the constant 
regions of the two heavy chains forming the body of the Y structure. This portion of 
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the antibody performs several tasks: it acts as an anchor to the B cell membrane and 
is responsible for the isotype and effector functions of the antibody. This is encoded 
by the constant region of the antibody genes. The isotype determines the biological 
processes mediated by the antibody, such as opsonisation of pathogens, complement 
activation and activation of mast cells to release chemical mediators. The "arms" of 
theY -shaped antibody molecule are made up of the light chains and the variable 
regions of the heavy chains. This portion of the antibody molecule contains highly 
variable loops and mediates specific binding to pathogens. This is the region that is 
generated by V(D)J gene recombination in and VJ gene recombination in the light 
chains in the primary (naive) antibody repertoire and further diversified by the 
action of activation-induced cytidine deaminase (AID) in the mature (post-
challenge) antibody repertoire (Barreto et al., 2005; Fleisher et al., 1997; Longerich 
et al., 2006; Neuberger et al., 2005). 
Primary diversification of the pre-immune naive antibody repertoire is 
achieved through a process called V(D)J recombination, in which individual gene 
segments of the Ig locus are recombined to create a functional antibody gene. In the 
case of B cells, variable (V), diversity (D), and joining (J)- type gene segments are 
recombined to form a V(D)J gene that encodes for the variable regions of the 
antibody heavy chain. The variable portion of the light chain is similarly encoded by 
a gene that is the result of recombination between V and J gene segments. Within 
the heavy chain gene locus there are 40 V gene segments, 2 5 D gene segments, and 6 
3 
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N terminus 
Variable Region 
Disulphide bonds 
Constant Region 
C terminus 
Figure 1. Y shaped structure of antibody molecule 
The constant region of an antibody molecule is shown in blue while the variable region located at the 
N terminus is shown in red. The variable region of antibodies is genetically modified by AID to 
improve antigen recognition and binding in an adaptive immune response. 
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J gene segments. The possible rearrangements of these 71 gene segments allow for 
6000 possible products. There are two light chains, kappa and lambda, which also 
recombine in a similar manner. Compounded with imprecise error-prone joining or 
random insertion and deletion of nucleotides at the borders of the V, D, and J 
segments, this combinatorial strategy results in millions of different antibody 
specificities from less than one hundred gene segments (Gellert, 2002). 
Naive B cells initially have a low affinity for any given antigen. To increase the 
specificity and affinity of the antibody, affinity maturation must take place, which 
requires secondary antibody diversification (Rajewsky, 1996; Fig. 2). Secondary 
antibody diversification requires the two AID-driven processes of Somatic 
Hypermutation (SHM) and Class-Switch Recombination (CSR; Muramatsu et al., 
2000; Martinet al., 2002; Okazaki et al., 2002; Revy et al., 2000; Fig. 3). The 
mutations induced by AID on ssDNA can undergo several repair mechanisms 
resulting in a full spectrum of mutations in a process called Somatic Hypermutation 
(SHM). Processing of the mutated base sites can also lead to DNA strand breaks 
potentially resulting in excision of DNA sequences. When this occurs in the target Ig 
locus, this is known as Class Switch Recombination (CSR). AID deaminates dC 
(deoxycytidine, cytidine within the DNA structure) converting it to dU (deoxyuridine, 
uracil within the DNA structure) at a relatively high rate of 10·3 fbpfcell generation, 
approximately 1 06-fold higher than the spontaneous mutation rate of the human 
genome (Rajewsky, 1996). Following AID action, the resulting dU in DNA may be 
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subject to a variety of error-free as well as error-prone DNA repair processes 
allowing the final mutation spectrum to encompass mutations of any of the four 
bases, adenine (A), cytidine (C), guanine (G) or thymidine (T) to any of the other 
three (Di Noia et al., 2007). 
While AID randomly mutates throughout the antibody gene, those 8 cells with 
higher affinity antibodies will outcompete 8 cells with lower affinity antibodies for 
binding to a limited pool of antigen in the germinal centers, thus receiving survival 
and/or proliferation signals. In this manner, AID-directed mutagenesis of antibody 
genes followed by cellular selection constitutes affinity maturation of 8-cells (Martin 
et al., 2002; Muramatsu et al., 1999; Muramatsu et al., 2000; Revy et al., 2000; 
Okazaki et al., 2002). 
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Figure 2. Affinity Maturation of B-cells. 
• lgG 
• lgM 
A pictorial representa tion of antibody levels and "maturation" in response to antigens. IgM isotype 
antibodies are initially produced and are low affinity. This is fo llowed by an exponential increase in 
concentration of the more specific antigen binding antibody isotype, IgG. (Adapted from Janeway, 
2008). 
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1.3 DNA targets of AID during secondary antibody diversification 
AID is a member of the apoliprotein B mRNA editing enzymes, a catalytic 
polypeptide-like (APOBECs) family of cytidine deaminase enzymes, of which there 
are 11 known members in humans (Muramatsu, et al., 1999). AID, a relatively small 
enzyme, at 24 kDa in size and a length of 198 amino acids in humans, is expressed by 
activated B-cells undergoing affinity maturation. It was initially presumed to be an 
mRNA editing enzyme due to homology with other APOBEC family member enzymes 
that act on RNA (Muramatsu et al., 2000); however, further work showed that it acts 
solely on single-stranded deoxyribonucleic acid (ssDNA) hotspots (trinucleotide 
sequence WRC where W =AfT, R = A/C), and not on RNA targets (Klemm et al., 
2009; Larijani et al., 2007b; Pham et al., 2003; Sohail et al., 2003). Several lines of 
evidence substantiate that ssDNA is the sole substrate for AID: a), hypermutation 
can be induced on transcribed episomal substrates and endogenous genes of 
hybridomas, fibroblasts, and bacteria with the expression of AID alone, and it is 
unlikely that the same mRNA target is present in all these species (Martin et al., 
2002; Petersen-Mahrt et al., 2002; Yoshikawa et al., 2002); b), AID has been reported 
to be physically localized at the switch region (S-region) during CSR in B cells, 
(Chaudhuri et al., 2007; Nowak et al., 2011; Ranjit et al., 2011); c), AID was shown to 
act on ssDNA and not on RNA or double-stranded DNA (dsDNA) following in vitro 
deamination reactions using purified AID (Bransteitter et al., 2003; Dickerson et al., 
2003; Larijani et al., 2007a; Pham et al., 2003); d), the levels of SHM and CSR are 
diminished by interfering with DNA-specific uracil repair processes (Di Noia et al., 
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2002; Rada et al., 2004 ), indicating that these processes result from the generation 
of uracil in DNA; e), the absence of Uracil-N-ONA glycosylase (UDG) and MutS 
protein Homologue 2 (MSH2), two DNA-specific repair factors that process dU only 
in DNA, causes an altered mutational spectrum at the Ig loci consistent with the lack 
of uracil processing in DNA; and f), the mutational spectrum and sequence 
preference of purified AID in vitro is nearly identical to that found at the Ig loci in 
mice and humans (Beale et al., 2004; Klemm et al., 2009; Larijani et al., 2005; Liu et 
al., 2008; Pasqualucci et al., 2007; Pham et al., 2003; Ramiro et al., 2004; Robbiani et 
al., 2008; Wang et al., 2004; Xue et al., 2006; Sohail et al., 2003; Yu et al., 2004) . 
Although it has been well established by several lines of investigation that ssDNA is 
the target of AID activity, the location(s) and manner(s) in which AID targets ssDNA 
in vivo have not yet been fully elucidated. 
The rate of AID-induced mutagenesis at a genetic locus correlates positively with 
transcriptional status (Peters et al., 1996; Storb et al., 1998; Fukita et al., 1998). SHM 
and CSR action is eradicated by deletion of Ig promoters, but can be recovered with 
non-Ig promoters (Fukita et al., 1998). The mechanism proposed for AID access to 
ssDNA is related to the transcriptional process; in the wake of helix unwinding by 
the RNA polymerase machinery, ssDNA in the transcription bubble, stemloops and 
R-loops or supercoiling induced-melted DNA provides AID access to ssDNA (Dayn et 
al., 1992). Stem loops structures are formed when partial self-complementarity DNA 
strands are present, allowing "bubbles" of unpaired ssDNA to form. R-loops 
structures are RNA-DNA hybrids (Thomas, White, & Davis, 1976) and are transiently 
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formed via preferential pairing of G-rich RNA with the cognate DNA permitting the 
sister DNA, to be left unpaired. Meanwhile, self-complementary strands are 
abundant in variable regions resulting in stem loop structures, while GC sequences 
are found at high frequency in the switch regions (S regions). Thus, various regions 
of the Ig locus exhibit an unusually high potential for the formation of stem loop and 
R loop structures during transcription (Yu et al., 2003; Huang et al., 2007). Both can 
provide ssDNA substrates for AID. 
In vitro studies have shown AID to have selective activity. AID deaminates dC 
efficiently in S-7 nucleotide bubble-type structures (Larijani et al., 2007b) and in R-
loop structures (Yu et al., 2005), yet it works inefficiently in stem-loop structures 
(Larijani et al., 2007b; Ronai et al., 2007; Parsa et al., 2012). Further research 
showed that AID can mutate both forward and reverse strands of supercoiled 
plasmid DNA in vitro (Shen et al., 2004 ), similar to the case in vivo, where AID 
induces mutations in the transcribed and untranscribed strands of Ig genes. DNA 
sequences adjacent to RNA polymerases paused at pre-determined locations 
undergoing transcription are also mutated by AID (Canugovi et al., 2009). These 
findings support the discovery that AID mutates DNA containing halted RNA 
polymerases (Pavri et al., 2010), and taken together, support a model of AID activity 
wherein AID acts on ssDNA structures of bubble stemloops and R-loops created 
during the transcription process. 
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1.4 Pathways mediating the full spectrum of AID mutagenesis 
As AID acts on ssDNA, it deaminates dC to dU, but this sole action can result in 
the full spectrum of transition and transversion mutations from any of the four 
bases (A, G, Cor T) found in DNA to another base. A transition mutation indicates a 
purine-to-purine or pyrimidine-to-pyrimidine base change, which is a change from A 
to G or G to A and from T to C or C to T, respectively. Transversion mutations are 
purine to pyrimidine or pyrimidine to purine base changes. The different mutation 
outcomes are due to the action of the various repair pathways that occur following 
the initial AID-mediated dC to dU conversion (Chadhuri et al., 2004; Neuberger et al., 
2005; Fig. 3). Firstly, the dU can go unrepaired and subsequently the DNA replicated, 
leading to a dC to dT transition mutation. Secondly, the dU:dG mismatch can be 
recognized by the DNA mismatch repair (MMR) machinery, followed by base 
excision repair (BER) which can involve error-prone polymerases leading to the 
introduction of further transition and transversion mutations surrounding the initial 
dU lesion. Thirdly, dU can be recognized and removed by Uracil-N-ONA glycosylase 
(UDG) generating an abasic site. As replication continues, transition and 
transversion mutations can occur across the abasic site (Di Noia et al., 2007). 
Through this wide variety of downstream mechanisms, the action of AID across the 
V(D)J-recombined exon and variable portions of the heavy and light chains leads to 
SHM, CSR and affinity maturation of antibodies. 
Repair mechanisms downstream of AID action can lead to abasic sites within 
ssDNA sequences. Abasic sites are labile and subject to natural or enzymatic 
11 
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cleavage through apurinicjapyrmidinic endonucleases that cleave the phosphate 
backbone. Following AID activity, multiple adjacent a basic sites on the two strands 
can lead to double strand breaks (DSB) in theS-regions located downstream of the 
constant gene segments of the Ig loci. These DSBs initiate recombination between S-
regions of different constant gene segments during CSR, leading to isotype or class 
switching of antibodies. This occurs through the excision of the first constant gene 
segment C~, which is then replaced by Cy, Ca, or C£ regions. This substitution 
changes the class or isotype of antibody from the default IgM to IgG, A or E during an 
immune response (deY ebenes & Almudena, 2006). Individuals with genetically 
inherited defective mutations of AID suffer from Hyper-IgM type immunodeficiency, 
and they are unable to mount a proper antibody response against pathogens due to 
the lack of SHM and CSR pathway initiation. Even common infections can become 
severe or even lethal for these individuals, which underlines the importance of AID 
activity for an efficient immune response (Durandy et al., 2005; Durandy et al., 
1996). 
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Figure 3. The mechanism of Somatic Hypermutation (SHM) and Class Switch 
Recombination (CSR) pathways. 
AID converts a target C to U within a nucleotide sequence, which is recognized by Mismatch Repair 
machinery (MMR). U is either replaced by T, repaired to Cor removed. If the U is removed by uracil-
N-ONA glycosylase (UDG), the a basic site can be filled with either A, G, Tall resulting in SHM. If the 
phosphate backbone of the DNA at the a basic site is cleaved, it can either be repaired or in the event 
of multiple cleaved sites called double-stranded breaks (DSBs) CSR can occur. (Adapted from de 
Yebenes, 2006) 
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1.5 The role of AID in tumorigenesis 
AID is a DNA mutator that greatly enhances the adaptive immune response; 
however, it has been shown to mutate off-target loci quite promiscuously. When AID 
acts on non-Ig genes, it can result in mutations or DSBs in a similar fashion as it does 
in the Ig genes, leading to dysregulation of gene expression through mutations or 
chromosomal translocations, resulting in cancers such as B cell lymphoma and 
leukemia (Kuppers et al., 2001; Kuppers, 2005). 
Studies with murine models have elucidated many links between AID activity 
and oncogene translocations. The IL-6 transgenic BALB/c strain is a well-studied 
mouse model that develops spontaneous plasmacytomas due to a c-Mycf lgH [v-Myc 
myelocytomatosis viral oncogene homlog (avian)] translocation, mirroring the 
translocations in Burkitt's lymphoma in humans. When these mice are AID deficient, 
c-Mycf lgH translocations are abolished, as are DSBs at the lgH and Myc loci (Ramiro 
et al., 2004 ). This provides direct evidence that AID is necessary for DSB formation 
at IgH and c-Myc translocation sites (Robbiani et al., 2008). AID deficiency was also 
shown to decrease the frequency of lymphoma development in the Bc/6 (B-cell 
CLL/lymphoma 6) transgenic mouse model, in which clonal splenic lymphomas 
result from Bc/6 deregulation (Pasqualucci et al., 2007). 
Sequencing a large number of genes from AID-deficient and sufficient mice 
showed that AID mutates up to 50 °;0 of all transcribed genes expressed in B cells 
(Lieu et al., 2008). Studies measuring the rate of AID-induced mutations in 
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transgenes throughout the genome, as compared to the rate of AID-induced 
mutations at the Ig locus, have shown that although AID can mutate genome-wide, it 
preferentially targets the lg locus 90 o/o of the time. Therefore, the highest rate of 
mutation found in non-Ig transgenes may approach 10 o/o; however, this is adequate 
to produce mutations and translocations in non-Ig genes (Robbiani et al., 2008), 
representing a significant risk to genome integrity. 
1.6 Clinical mutations and translocations of oncogenes and AID activity 
In the Western Hemisphere, the vast majority of lymphomas originate in mature 
B cells (Kuppers, 2005). Many of these cancers have been found to have mutations 
and translocations of several proto-oncogenes - cMYC/ IgH in Burkitt's Lymphoma 
(BL), BCL2/IgH in follicular lymphoma (FL), BCL-6/IgH in diffuse large B cell 
lymphoma (DLBCL) -strongly suspected to be due to aberrant AID activity. 
Promiscuous AID activity has also been suggested to result in other cancers 
including multiple-myeloma and chronic lymphocytic leukemia (CLL; Shen et al., 
1998; Pasqualucci et al., 1998; Kuppers et al., 2001). In human studies, mutations 
and translocations in signature AID hotspot motifs (WRC) have been reported in 
oncogenes in lymphoma cells. For instance, BCL6 gene disruption is associated with 
various malignancies. In DLBCL, BCL6 is translocated in 35 % of cases and mutated 
in 73 °/o (Migliazza, et al., 1995). AID generated c-Myc-IgH translocations have been 
shown to cause BL in mice. Similarly, point mutations in tumour suppressor genes 
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such as retinoblastoma (Rbl), p19 and p53 are displayed in various B-cell tumours 
and can affect the progression of the disease, as well as its development (Kuppers et 
al., 2001). 
Many oncogenes c-Myc, BCL-6, FAS (Fas cell surface death receptor), P/M-1 (Pim-
1 oncogene), PAX-5 (Paired box 5), and RHOH (Ras homolog family member H) in 
lymphomas harbour mutations and/or translocations in AID hotspots (Gordon et al., 
2003; Muschen et al., 2000; Pasqualucci et al., 1998; Pacsqualucci et al., 2000; Shen 
et al., 1998). The role of AID in the commencement of these diseases is further 
evidenced by the fact that the majority of tumours originate from the centro blast or 
post-centroblast stage of B cell development, the stage in B cell development where 
AID is expressed. Lastly, other translocations of proto-oncogenes almost always 
involve a translocating partner within the Ig heavy chain locus such as the JH orS-
region, the very region that AID targets to mediate SHM and CSR (Kuppers et al., 
2001; Willis et al., 2000). 
AID expression levels can also be indicative of human prognosis of CLL and 
DLBCL, where AID levels are associated with poor prognoses for patients (Heintel et 
al., 2004; Lassos et al., 2004; McCarthy et al., 2003; Reiniger et al., 2006). AID activity 
is believed to further mutate and destabilize the genomes of lymphomas. For 
instance, levels of AID were correlated to Imatinib resistance in CML. The drug 
resistance was shown to arise from hypermutations in tumour suppressor and/ or 
DNA repair genes after the transduction of AID into tumour cells (Klemm et al., 
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2009). While some progress has been made in the down regulation of oncogenesis 
by reducing CSR (Gazumyan et al., 2011) a better understanding of AID targeting 
could enhance treatment of cancers of B-cell origins. With future insight of the 
mechanism of AID DNA editing, an inhibitor could be developed as a therapeutic 
option for patients with cancer resulting from aberrant AID activity, reducing 
progression of the disease while maintaining immune function. 
1.7 The biochemical features and putative structure of AID 
Largely due to difficulties with expression and purification of highly 
genotoxic enzymes such as AID, many aspects of its structure, enzymatic 
mechanism(s), and modes of AID binding to DNA remain unknown. Although the 
enzymatic mechanism has not been fully established, evidence suggests that AID 
acts on dCs that are flipped outside of a DNA strand and no longer aligned in 
stacking formation with neighbouring bases. Support for this claim includes the 
precedence of base flipping mechanisms in other deaminase enzymes, including 
tRNA adenosine deaminase (TadA) and adenosine deaminase acting on dsRNA, 
(ADAR; Losey et al., 2006; Stephens et al., 2000) and in DNA modifying enzymes like 
methyltransferases and uracil glycosylases (Holz et al., 1998; Slupphaug et al., 1996; 
Jiang et al., 2002). Based on our model of AID (Fig. 4 ), dC would have to be flipped 
out of the DNA sequence away from adjacent bases to fit into AID's catalytic pocket, 
a process which occurs for a related enzyme in the APOBEC family, APOBEC3G 
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(Deng, et al., 2010). Moreover, the size of the enzyme is too large to fit within the 
small S-7 nucleotide ssDNA bubble structures that AID preferentially deaminates 
(Larijani et al., 2007a). Within these small nucleotide bubbles, space is limited and 
dC is more likely to be unstacked and flipped out of the sequence due to torsional 
constraints with adjoining bases, further supporting this model. 
Biochemical analysis of AID enzymatic catalysis shows an unusually slow rate 
of reaction compared to most other enzymes. AID has a rate of approximately one 
deamination every few minutes (Larijani et al., 2007b) as opposed to hundreds to 
thousands of reactions per second for most enzymes. Remarkably, the 
aforementioned ADAR deaminase also has a slow enzymatic velocity, and utilizes a 
base-flipping mechanism on its dsDNA substrate, suggesting that a slow enzymatic 
velocity may be an inherent feature of a base-flipping mechanism (Stephens et al., 
2000; Yi-Brunozzi et al., 2001). While this sluggish rate may be due to the in vitro 
AID production via bacterial expression purification processes (Coker et al., 2006), it 
has been confirmed by another research group using an independent AID expression 
system, (Pham et al., 2003) validating slow activity as an innate characteristic of AID 
enzymatic activity. A slow rate could be a protective mechanism guarding the 
genome against aberrant AID mutations and directing AID's preference for the Ig loci 
over off-target genes. This idea is reinforced by the higher rate of activity evidenced 
by high levels of mutations and chromosomal breaks induced in bacterial lines by 
mutant human AID, produced through random mutagenesis and selected by 
bacterial papilation assay (Wang et al., 2009). The intrinsic properties of AID may 
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very well have evolved as an essential protective mechanism against its 
promiscuous nature. 
AID has an unusually high ssDNA binding affinity in the nM range, several 
orders of magnitude above typical DNA-binding enzymes. This characteristic, 
coupled with a long complex half-life of approximately 8 minutes, provides an 
explanation for the slow catalysis and in vitro enzymatic processivity of AID (Larijani 
et al., 2007b ). AID processivity refers to the fact that in a pool of DNA substrates, 
AID mutates very few targets, but these targets are deaminated quite heavily. This 
has been suggested to be due to the high DNA binding affinity, such that there is a 
much higher likelihood of AID dissociating and re-associating with the same 
substrate once it has acted on ssDNA. This could potentially facilitate further 
recruitment and interaction with other proteins involved in SHM and CSR processes 
(Ranjit, et al., 2011). 
Variation in the activity of AID coincides with the different binding affinities 
of AID for each different ssDNA substrate structure studied (Larijani et al., 2007); 
thus, the binding process is a significant factor when determining AID's enzymatic 
velocity. This effect was found to occur due to residue mutations affecting both 
activity and binding affinities. These mutations were predicted to be within the core 
of the structure of AID (Wang et al., 2009). Such evidence would imply that there are 
likely two sets of regions of AID that are responsible for regulating its activity: a 
select few residues found near the catalytic zinc (Zn) coordinating site that engage in 
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enzymatic deamination, and several residues found on the surface involved in 
ssDNA binding and potential multimerization. 
1.8 Modeling the putative 3-dimensional structure of AID 
To date, the structure of the AID protein has not been resolved. In order to 
study its mechanism and substrate binding functionalities, the structure is of utmost 
importance. Based on the experimentally determined X-ray structure of the protein 
family member APOBEC3G, the core and surface topography structures of AID were 
modeled; from which it was hypothesized there are two potential ssDNA binding 
grooves. As with APOBEC3G, the model shows AID as having a core of five beta 
strands surrounded by six alpha helices (Fig. 4). There are several reasons to believe 
that this model is accurate: Firstly, the model recapitulates the canonical position of 
the Zn-coordinating residues [two cysteines (C) and one histidine (H)], which are 
contributed by the ends of opposing alpha helices in all other deaminases. In the AID 
model, the residues HS6, C87, and C90 are located proximal to a proton-donor 
glutamic acid (ES8). Thus, the model generates a viable catalytic site akin to that of 
other crystallized deaminases (Ireton et al., 2003; Carter Jr., 1995; Conticello et al., 
2007; Chen et al., 2008; Holden et al., 2008). In support of this notion, mutagenesis 
of HS6, C87, C90, and ES8 leads to an inactive enzyme (Dickerson et al., 2003; M. 
Larijani, unpublished observations). Secondly, the model recapitulates secondary 
structure predictions based on the solved structure of other bacterial, yeast, and 
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human cytidine deaminases (Ko et al., 2003; Losey et al., 2006; Chen et al., 2008; 
Holden et al., 2008). Thirdly, analysis of the AID surface topography in this model 
reveals a highly charged surface with a large proportion of positive residues, such as 
Arginine (R) and Lysine (K), consistent with our previous finding of exceptionally 
high affinity binding of AID to negatively charged ssDNA. This feature may also 
explain difficulties in the purification (and consequently crystallization) of AID, 
necessitating relatively bulky tags such as GST (Sohail et al., 2003; Larijani et al., 
2007a) and MBP (Kohli et al., 2009). Fourthly, two putative DNA-binding grooves 
were observed passing over the catalytic pocket (Fig. 4). These grooves are --10 
Angstroms (A) in width at their widest points and are lined with a high proportion of 
positively charged residues. Given that double-helical dsDNA is-- 20 A wide, the size 
of these grooves is consistent with the restriction of AID activity to ssDNA (Pham et 
al., 2003; Sohail et al., 2003; Larijani et al., 2007a) and its makeup is consistent with 
high affinity binding to ssDNA (Larijani et al., 2007a). Lastly, a recent random 
mutagenesis study identified dozens of AID single, double, triple, and multiple 
mutants with altered enzymatic velocities and the position of many, but not all, of 
these residues are predicted to be proximal to the catalytic site (Wang et al., 2009). 
The prediction model shown in Figure 5 may be a relatively accurate 
prediction of an AID monomer structure, but it does not account for the quaternary 
structure of AID. Though the stoichiometry of enzymatically active AID has been a 
contentious issue in the literature, recent evidence suggests that the native 
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a. b. 
c. 
Figure 4. Human wild-type AID (a.) ribbon diagram, (b.) surface diagram, and (c.) 
combined diagram. 
(a.) Ribbon model, (b.) surface model and (c.) combined model was predicted and generated using 
Pymol v1.30 based on the experimentally determined X-ray structure of the protein family member. 
As with APOBEC3G, the model shows AID as having a core of five beta strands surrounded by six 
alpha helices, coloured for visual distinction. The surface model is coloured according to residue; 
positively charged residues are shown in blue, negatively charged residues are shown in red, 
aromatic residues are yellow and purple is the Zn binding pocket. 
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stoichiometry of AID is likely a dimer or tetramer. Purified AID appears to migrate as 
a tetramer (Dickerson et al., 2003) and when two differently tagged versions of AID 
were co-expressed in the same cell, co-immunoprecipitations indicated AID forms a 
dimer or multimer (Ta et al., 2003). By separating purified GST- or His-tagged AID 
on a size-exclusion column and measuring the activity of various fractions, the 
highest activity levels in fractions consistent with the size of a tetra mer was found 
(Larijani et al., 2007a). APOBEC2 is 75 °/o identical to AID, and exists as a tetramer 
formed by head-to-head interaction of two dimers (Prochnow et al., 2007). 
Mutational studies disrupting putative dimerization domains of AID based on 
homology of primary sequence with other family members, as well as the residues 
involved in multimerization of APOBEC2, have yielded an enzyme with decreased 
activity (Prochnow et al., 2007). Whilst the majority of the literature supports a 
model where AID is a tetramer, there are studies that challenge this notion. For 
instance, a study using atomic force microscopy measurement of free AID in solution 
found that enzymatically active AID acts as a monomer (Brar et al., 2008). For the 
final word on the tertiary and quaternary structure of AID, we await the solution of 
AID structure by NMR (Nuclear magnetic resonance) or X-ray crystallography. 
1.9 Identification of two putative ssDNA binding grooves 
The AID structural model revealed two putative ssDNA binding grooves along 
the surface- Groove 1 and Groove 2 (Fig. 5). We chose these two grooves due to 
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their close proximity to the zinc-coordinating site, their correct diameters to 
accommodate ssDNA, but not dsDNA (- 6 A), and the presence of multiple positively 
charged residues, which are likely candidates for interaction with the negatively 
charged DNA. Both putative binding grooves pass over the catalytic pocket of AID. 
Based on these features, it was hypothesized that positively charged residues within 
this groove interact with DNA and are involved in binding and activity. It was 
further reasoned that if positively charged residues were mutated to amino acids 
with negative or neutral charges, ssDNA binding and enzymatic activity would be 
altered such that binding and therefore activity would be reduced. The reverse 
should also be true, whereby negatively charged residues repel negatively charged 
DNA and mutating these to positively charged or neutral residues would more 
strongly attract ssDNA, which should result in higher affinity binding. Since work in 
our lab has previously shown that higher ssDNA binding affinity by AID correlates 
with higher deamination activity, we would also expect to produce mutated 
enzymes with higher deamination activity; however, it is possible that there is an 
optimal ssDNA binding affinity, beyond which, higher affinities would actually 
diminish the enzymatic activity, as the enzyme would remain bound to each 
substrate for a longer period and reduce the rate of the catalytic cycle (Fig. 6). 
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Groove 1 Groove 2 
Figure 5. AID Model and Putative Binding Grooves 1 & 2. 
Proposed AID structure was modelled on AID sequence and sequentially homologous APOBEC-1 
structure. Positively charged residues are shown in blue, negatively charged residues are shown in 
red, aromatic residues are yellow and purple is the Zn binding pocket. The track of Groove 1 and 
Groove 2 are highlighted by black lines. The AID model was rotated slightly to highlight Groove 2. 
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Figure 6. Binding Affinity versus Enzyme Activity. 
A proposed relationship between the binding affinity of enzyme and the resulting activity. At lower 
binding affinity an enzyme can operate on a substrate and easily progress to the next substrate. The 
activity increases with binding affinity and maximizes at a peak. These high levels can cause errant 
over activity. As the binding affinity increases further the enzyme is less able to release substrate and 
act on another. As a result, enzyme activity decreases. The enzyme activity level will reach a level that 
is neither too promiscuous nor too low when the binding affinity is within this "optimal zone". 
Binding affinity above this threshold will cause enzymes to dock substrate too tightly and result in a 
low substrate turnover rate and consequently, a very low activity level. 
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To study this enzyme, we have modeled the structure based on the linear 
structure of AID (Fig. 7) homologous family member enzymes APOBEC3G and 
APOBEC2 whose structures have been experimentally determined by NMR or X-ray 
crystallography (Fig. 8; Prochnow et al., 2007; Chen et al., 2008; Holden et al., 2008). 
We then identified two putative DNA binding grooves and made various point and 
multi-residue mutations in and around each of these two grooves, illustrated in a 
linear representation of the sequence of AID (Fig. 7). We then studied the enzymatic 
velocities and binding affinities of the mutant enzymes in order to ascertain the 
involvement of each putative groove in ssDNA binding. Using enzyme mutagenesis, 
the involvement of specific residues in AID activity and binding can be effectively 
explored, as shown in APOBEC and other enzyme studies (Kao et al., 1996; 
MacGinnite et al., 1995; Mu et al., 2012; Hu et al., 2013). 
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Figure 7. Linear AID structure. 
A linear representation of AID with known domains indicated. NLS = Nuclear Localization Sequence. 
NES = Nuclear Export Signal. The amino acid residues selected for mutation are indicated by blue 
(positively charged) and red (negatively charged) bands. 
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a. b. 
Figure 8. (a.) APOBEC-3G Surface Model and (b.) combined Surface and ribbon model. 
Proposed charge surface model and ribbon and charge surface model was predicted using the AID 
sequence and sequentially homologous APOBEC-1 structure. Positively charged residues are shown 
in blue, negatively charged residues are shown in red and purple is the Zn binding pocket. 
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1.10 Hypothesis 
Using the 3D model of AID (Fig. 5), it is hypothesized that positively charged 
residues lining Groove 1 and Groove 2 adjacent to the catalytic pocket are relevant 
for negatively charged ssDNA substrate binding and control of AID activity. If these 
positively charged residues are altered, enzyme activity and binding should likewise 
be altered. Changing the positive residues to those with neutral or negative charge is 
expected to reduce binding and activity of the resulting mutant enzymes. 
Conversely, converting negatively charged residues within the putative binding 
grooves to positively charged residues is expected to increase binding to negatively 
charged substrate and therefore increase enzyme activity. 
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Chapter 2 Materials and Methods 
2.1 Overview of AID mutagenesis and analyses: 
The wt AID sequence was altered using site-directed mutagenesis as a 
strategy to create individual or compound AID mutants. The modified strands were 
subsequently verified with sequencing by Macrogen and base analysis with DNA Star 
software. Mutant AID sequences were translated into protein and the purified 
enzyme was assayed for overall activity, substrate binding and subsequent kinetic 
assays, if sufficient AID activity was retained. Figure 9 outlines the overall 
experimental process. 
Mutagenesis 
& Sequence _ 
Analysis 
Protein 
Synthesis & _ 
Purification 
Figure 9. Mutant Analysis. 
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Mutant AID enzymes were designed, produced and tested using various assays to study enzyme 
activity and binding. 
2.2 Site Directed Mutagenesis 
The positively charged amino acids, lysine (K) and arginine (R), within putative 
binding grooves 1 and 2 were chosen for mutation to a negatively charged amino 
acid, aspartic acid (D), or to the relatively inert residue alanine (A) . Negatively 
charged amino acids, aspartic acid, and glutamic acid (E) were likewise converted to 
arginine. If associated with DNA binding, these mutations should disrupt AID activity 
between the mutant AID protein and the ssDNA substrate. 
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Primer pairs of approximately 30 nucleotides were designed for each amino acid 
residue under investigation (Table 1). GC clamps were included at either end of the 
primer to ensure specific binding to the mutation site. Lyophilized primers (IDT) 
were resuspended in MilliQ HzO to 100 nM; 12.S ng of primer and of its 
complementary strand were used in a SO J.!L site-directed mutagenesis reaction 
containing 32.S J.!L MilliQ water, 10 J.!L High Fidelity S X PCR Buffer, 1 J.!L High 
Fidelity DNA polymerase (NEB), l.S J.!L 10 mM dNTP mixture, and 2S ng of pGEX-Sx-
3 GST H long linker AID plasmid template. The thermal cycler steps were as follows: 
98 °C for 1 min, 98 oc for 30 s, SO oc for 4S s, and 72 oc 6 min repeated 30 times, 
followed by a final extension step of 72 °C for 10 min followed by a 1S °C hold. The 
reactions were stored overnight at 4 °C and digested the following morning with 0. 7 
J.!L Dpnl methylation dependent restriction endonuclease for 2 h (hours) at 37 °C. 
Samples were then dialysed to remove impurities and excess salts using MilliPore 
0.02S Jlm membrane filters on MilliQ water for 1 hat room temperature. The 
purified samples were transferred to l.S mL microcentrifuge tubes and 
concentrated under vacuum using a SpeedVac Concentrator (Savant). Fifty J.!L of 
Top10 DHSa cells were transformed with S J.!L of the concentrated PCR product, 
stirred gently, and left to sit on ice for 20 min. They were then heat shocked at 42 oc 
for 90s followed by an addition of 200 J.!L of Super Optimal Broth with Catabolite 
repression (SOC) media (Super Optimal Broth with added glucose used for bacterial 
transformation). The samples were incubated at 37 oc in a shaker for 1 h, after 
which 2SO J.!L was plated on LB (Lysogeny broth or Luria-Bertani medium)-
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ampicillin (37 g LB +Agar /1 L MilliQ dHzO, 100 11g/mL ampicillin) and incubated 
overnight at 3 7 °C. Five to twenty of the resulting colonies were selected for each 
mutant AID and grown in 5 mL LB +ampicillin [100 Jlg/mL] media overnight at 37 
°C and gently stirred at 225 rpm. Each culture was transferred to a 1.5 mL micro 
centrifuge tube and pelleted by centrifugation. Plasmid DNA was extracted using a 
QIAprep Spin Mini prep kit (Qiagen) and microcentrifuge. The resulting plasmids 
were verified for cloned inserts via EcoR1 restriction digest (0.3 J.!L, 2 hat 37 °C) . 
Mutations were confirmed by DNA sequencing (Macrogen Inc., Korea) and 
confirming amino acid signals using DNA Star software. Multiple mutants (Table 2) 
were created through site directed mutagenesis using plasmid of a confirmed 
mutant as the template with the designed primers of a secondary mutant sequence. 
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Table 1. Designed Primers 
Primer sequences and complementary strands were designed using 
approximately 30-nt bases ofwt AID sequence. Point mutations were 
introduced by conservatively changing the coding bases for each point 
mutation to preserve maximum amount ofwt AID sequence. 
K22D ccgctgggctgacggtcggcgtgagacctacc 
K22Dcomp ggtaggtctcacgccgaccgtcagcccagcgg 
K22A ccgctgggctgcgggtcggcgtgagacctacc 
K22Acomp ggtaggtctcacgccgacccgcagcccagcgg 
R24D ccgctgggctaag~gaccgtgagacctacc 
R24Dcomp ggtaggtctcacggtcacccttagcccagcgg 
R24A ccgctgggctaag~gcgcgtgagacctacc 
R24Acomp ggtaggtctcacgcgcacccttagcccagcgg 
R25D ggctaagggtcgggatgagacctacctgtgc 
R25Dcomp gcacaggtaggtctcatcccgacccttagcc 
R25A ggctaagggtcgggctgagacctacctgtgc 
R25Acomp gcacaggtaggtctcagcccgacccttagcc 
E26R ggctaagggtcggcgtaggacctacctgtgctacg 
E26Rcomp cgtagcacaggtaggtcctacgccgacccttagcc 
E26A gctaag~cggcgtgcgacctacctgtgc 
E26Acomp gcacaggtaggtcgcacgccgacccttagc 
RSOD ggactttggttatcttgacaataagaacggctgcc 
RSODcomp ggcagccgttcttattgtcaagataaccaaagtcc 
RSOA ggactttggttatcttgccaataagaacggctgcc 
RSOAcomp ggcagccgttcttattggcaaga taaccaaagtcc 
K52D ggttatcttcgcaatgacaacggctgccacgtgg 
K52 Dcomp ccacgtggcagccgttgtcattgcgaagataacc 
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K52A ggttatcttcgcaatgcgaacggctgccacgtgg 
K52Acomp ccacgtggcagccgttcgcattgcgaagataacc 
R63D ggaattgctcttcctcgactacatctcggactggg 
R63Dcomp cccagtccgagatgtagtcgaggaagagcaattcc 
R63A ggaattgctcttcctcgcctacatctcggactggg 
R63Acomp cccagtccgagatgtaggcgaggaagagcaattcc 
D89R ggagcccctgctaccgctgtgcccgacatgtgg 
D89Rcomp ccacatgtcgggcacagcggtagcaggggctcc 
D89A ccgctacatctcggactgggccctagaccctggcc 
D89Acomp ggccacatgtcgggcacaggcgtagcaggggctcc 
D96R gcccgacatgtggcccgctttctgcgagggaaccc 
D96Rcomp gggttccctcgcagaaagcgggccacatgtcgggc 
D118R cctctacttctgtgagcgccgcaaggctgagcc 
D118Rcomp ggctcagccttgcggcgctcacagaagtagagg 
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2.3 AID Protein Purification 
Protein production began with transformation of SO ~L Escherichia coli BL21 
(DE3) cells with S ~L of sequenced AID plasmid, letting the cells sit on ice for 20 min. 
They were then heat shocked for 90 s at 42 oc and supplemented with 200 ~L of SOC 
media before incubation at 37 °C and 22S rpm for 1 h. Two hundred and fifty ~L of 
culture was plated on LB-ampicillin and incubated at 3 7 °C overnight. The next day, 
a 2SO mL LB-ampicillin (100 ~g/mL) culture was inoculated with one colony of 
glycerol stock of transformed DE3 cells, and then incubated at 37 °C in an orbital 
shaker (Forma Scientific) until the culture reached the log phase of growth. Protein 
production was induced in the cells with 2SO ,_,.,L 1M isopropyl-~-D­
thioglactopyranoside (IPTG) to activate the lac gene promoter. The culture was then 
incubated overnight at 16 oc and approximately 180 rpm in a PsychoTherm 
controlled environment incubator shaker. The next morning, the culture was 
transferred to a 2SO mL Nalgene polypropylene bottle and pelleted using a Sorvall 
Evolution RC Ultra Centrifuge at 4°C, SOOO rpm for 12 min. After decanting the 
supernatant, the pellet was re-suspended in 20 mL of cold 1 X Phosphate buffered 
saline (PBS) and transferred to a SO mL Falcon tube on ice. 
A French pressure cell press (Thermospectronic) was used to lyse there-
suspended cells twice, rinsing the French pressure cell with cold 1 X PBS before and 
after use. The lysate was ultra centrifuged in a Nalgene polypropylene Falcon tube at 
SOOO rpm and 4 oc for 11 min (minutes) to remove cell waste. The AID protein was 
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isolated from the lysate supernatant following application to Glutathione sepharose 
beads (Amersham) and subsequently eluted as per the manufacturer's 
recommendations. Fractions of the elution were collected at 4 oc in 500 JlL volumes 
of 15-30 aliquots for each protein and kept on ice. The fractions were then tested 
for optical density (OD), protein concentration and purity by nanodrop 
spectrophotometry (Thermo Scientific) at 260 and 280 nm wavelengths. Fractions 
containing more than 1 mgfmL of protein were combined and dialyzed using 
Snakeskin R Pleated Dialysis Tubing (Thermo Scientific) in Dialysis Buffer (1mM DL-
Dithiothreitol, 20mM Tris-HCl and 100 mM NaCl) overnight at 4 °C. The buffer was 
replaced in the morning to dialyze the fractions 3-5 h further, after which the 
purified protein was aliquoted 50 JlL per 1.5 mL micro centrifuge tube and flash 
frozen in liquid nitrogen for 30 s. The aliquots were then stored at -80 °C. 
Each preparation of purified GST -AID protein was run against Bovine Serum 
Albumin (BSA) standards on sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (SDS-PAGE) and Coomassie staining to test for protein 
concentration, purity, and expression levels. AID protein concentrations were thus 
determined in comparison to BSA titrations and used to equalize AID volumes for 
assay use. Deamination and Electrophoretic Mobility Shift Assays (EMSA) were 
performed with AID to test for activity and complex formation with substrate. 
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2.4 AID Substrate Preparation 
The 56 base pair long ssDNA substrate, H2S2bub7, was prepared with a 7-
nucleotide single-stranded target site known as a bubble, containing one target 
cytidine. The bottom strand of the substrate contains the target site trinucleotide 
sequence thymidine-adenosine-cytidine (T AC) and was purified by High 
Performance Liquid Chromatography. The top strand used was BHagtop, purified by 
desalting. Their sequences are as follows, with * indicating the target cytidine: 
BHagtop: 
5'-AGA TCC TGC CCC GGC ACT TCG CCC GGG TTT TTC CAG TCC CTT CCC GCT TCA 
GTG AC- 3' 
HS2bub7 (TAC): 
5'-GTC ACT GAA GCG GGA AGG GAC TGT GTA C*TT CCG GGC GAA GTG CCG GGG CAG 
GAT CT- 3' 
The substrate was radioactively labelled using the following reaction: 1 ~L of 2.5 
pmolj~L TAC, 1 ~L lOX polynucleotide kinase (PNK) buffer, 1 ~L PNK enzyme, 3 ~L 
15 ~Ci/~L ATP-[y-32P], and 4 ~L of autoclaved MilliQ water. Upon mixing, the 
reaction was incubated at 37 oc for 53 min then at 65 oc for 10 min to deactivate the 
enzyme. It was then brought to 4 °C, briefly centrifuged, mixed with 10 ~L of 1X Tris-
EDT A (TE) buffer and separated from unlabelled oligonucleotides using a mini Quick 
Spin Column (Roche). The reaction was applied to the column and spun at 3000 rpm 
for 3 min. To the resulting flow through, 5 ~L 1 M KCl, 3 ~L 2.5 pmol/~L BHagtop 
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and adequate autoclaved MilliQ water was added to a final volume of 50 J!L. This 
mixture was incubated at 96 oc for 2 min, then at 1 oc lower temperature each 
minute for 14 min, 1 oc decrease every 30 s for 4 7 min, followed by a decrease of 2 
oc every 30 s until6 oc was reached. The labelled substrate was then stored at -20 
2.5 Deamination Activity Assay 
The alkaline cleavage assay was used to measure and quantify the enzymatic 
deamination activity of AID. For this assay, 1.6 J.lg of AID protein was incubated with 
0.15-50 fmol of labelled TAC substrate in 100 mM phosphate activity buffer at pH 
7.28 to a final reaction volume of 10-15 J!L, at 37°C for 2 h. The cytidines converted 
to uracils were removed using 1 unit of Uracil-N-ONA glycosylase (UDG) by adding 
0.2 J!L of UDG enzyme (NEB), 2 J!L UDG buffer, and 7.8 J!L autoclaved MilliQ water to 
the reaction, followed by incubation at 37 oc for 30 min. The resulting alkali-labile 
abasic site in the DNA phosphate backbone was cleaved by adding 2M NaOH to a 
final concentration of 200 mM, followed by incubation at 96 oc for 5 min. The 
reaction mixture was incubated under the same conditions upon the addition of 10 
J!L Formamide loading dye (0.25% Bromophenol Blue dye and 9So/o Formamide). 
The reactions were then loaded onto a 14% denaturing acrylamide gel (14 °/o 
acrylamide:bisacrylamide 19:1, 25 °/o Formamide, 1X Tris Borate EDTA (TBE) and 
electrophoresed in 1X TBE running buffer for 3 h at 300 V and room temperature. 
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The resolved gel was then exposed to a blanked Phosphor Screen GP (Kodak Storage, 
BioRad) for 16-24 hand imaged using a Phosphorimager scanner (Molecular 
Dynamics). 
2.6 Affinity-Binding Assay 
Substrate-AID binding affinity was measured using EMSA; 1.6 ~g of AID was 
incubated with 0.1S-SO fmol of labelled TAC substrate in EMSA binding buffer (2 ~M 
MgCl, 1 mM OTT, SO mM NaCl, and SO mM Tris pH 7.S) for a final reaction volume of 
10-1S flL at 2S oc for 1 h. Reactions were UV-crosslinked on ice using the optimum 
setting of a UV-crosslinker (Stratagene), rotated 180 degrees and repeated. EMSA 
loading dye (0.2S 0/o Bromophenol Blue dye, 0.2S 0/o Xylene Cyanol dye, 49.7S 0/o 
Glycerol, and 49.7S 0/o autoclaved MilliQ water) was added to each sample, before 
they were electrophoresed on an 8 °/o native gel (6 °/o Glycerol, 8 °/o 
acrylamide:bisacrylamide 19:1), in O.SX TBE buffer for 3 h, at 300 V and 4 °C. 
Following electrophoresis, gels were dried onto chromatography paper (Whatman) 
using a slab dryer, at 80 oc for 2 h, then exposed to a blanked Phosphor Screen GP 
(Kodak Storage, BioRad) for 16-24 hand imaged using a Phosphorimager scanner 
(Molecular Dynamics). 
40 
2. 7 Quantification of Assay Gel Images 
Gel images were then quantified 3 times independently to ensure accuracy of 
data analysis using Quantity One 1-D Analysis Software (BioRad). Activity data was 
plotted as substrate concentration versus percentage product formed. The velocity 
(fmolefmin/~g) of the enzyme/substrate reaction was calculated using the 
following formula: 
({(Fraction of substrate product) x [substrate concentration (fM)]}j(time of incubation, in mins)) 
mass of AID (mg) 
Velocity data was then graphed using GraphPad Prism software as substrate 
concentration versus velocity, with repeated experiments averaged with standard 
error of mean (SEM) calculated and shown on plots using the Graph Pad Prism 
software. The Michaelis-Menten constant, Km, was determined from the plotted 
activity data, using in-software non-linear regression, where Km is the substrate 
concentration at half of the maximum reaction velocity, taken at saturation. 
Binding data was plotted as free versus bound concentration of substrate. 
The dissociation constant was determined from the graphed data using the 
GraphPad Prism software's non-linear regression. The law of mass action formula 
can be rearranged to find Kd: 
Law of Mass Action: [Bound]= {[Boundmax] x [free]}/{Kd +[free]} 
Kd = {[Boundmax] x [free]/ [Bound]} - [free] 
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The maximum concentration of bound substrate is taken at saturation and is 
assumed to signify total active AID in molar quantities. 
2.8 Structural modeling of wt and mutant AID 
The structures of wt AID and mutant AID were modeled using the Swiss protein 
data bank (http:/ fswissmodel.expasy.org/repository /). The resolved crystal 
structure of family member APOBEC-3G (Fig. 8) catalytic domain (PDB ID: 3EIU) 
was chosen as the best-fit template by the database and lowest energy state 
predictions were generated. Analysis of predicted models and generation of ribbon 
and surface charge models were performed using Pymol v1.30 (Fig. 4; Chen, Harjes, 
Gross, Fahmy, Lu, & Shindo, 2008; Holden, Prochnow, Chang, Bransteitter, Chelico, & 
Sen, 2008). 
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Chapter 3 Results 
3.1 AID Sequence and Mutagenesis 
Although all residues selected for individual or compound mutagenesis line 
the suggested binding Groove 1 or 2 on the surface of the AID model, they represent 
different regions within the linear primary sequence of AID (Fig. 7). Residues within 
these grooves were mutated to other residues bearing an opposite or neutral charge, 
followed by comparison with wt AID for activity and ssDNA binding. To evaluate if 
combined mutations would have an additive effect on AID action, selected multiple 
mutants were designed and tested. Mutant AID proteins that were enzymatically 
active or bound substrate underwent further testing to determine the precise 
enzyme velocity kinetics, Km, and ssDNA binding affinities, Kt (Table 3). 
3.2 Overview of AID mutagenesis 
All together, 24 AID mutants were constructed: 18 single and 6 multiple 
mutants (Table 2). Of the single mutants, 6 were mutations of positive to negative, 6 
positive to neutral, 4 were mutations of negative to positive and 2 were negative to 
neutral residues. Twelve of these mutations were in putative Groove 1 and 8 were 
in putative Groove 2. Of note, the R24D and R24A mutations are located in both 
Grooves and are included in the number of mutants for each groove. 
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Each mutant AID enzyme was tested for activity compared to wt AID using 
the alkaline cleavage assay. The imaged gels show resolved substrate where 
deaminated substrate indicates enzymatic activity (Fig. 10). For mutant enzymes 
that showed activity, the alkaline cleavage experiments were repeated with varying 
levels of substrate and a standardized amount of enzyme to determine kinetic 
activity, or velocity, of each mutant (Fig. 11). 
In addition to activity assays, each mutant AID enzyme was also tested for 
binding ability compared to wt AID with the EMSA assay. The imaged gels show 
resolved bound and unbound substrate (Fig. 12). All mutant enzymes demonstrated 
substrate binding ability and were subsequently tested repeatedly with the EMSA 
assays using varying levels of substrate and a standardized amount of enzyme to 
determine kinetic binding, or binding affinity, of each mutant (Fig. 13). 
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Table 2. Mutation 
Amino Acid Opposite Charge Neutral Charge 
Groove 1 
K22 K22D K22A 
R24 R24D R24A 
R25 R25D R25A 
R63 R63D R63A 
D89 D89R D89A 
D96 D96R D96A* 
D118 D118R D118A* 
Groove 2 
R24 R24D R24A 
E26 E26R E26A 
RSO RSOD RSOA 
K52 K52D KS2A 
Multiple Mutants 
K22D/ KS2D 
K22D/ R63D 
R24D/ R63D 
R25D/ R63D 
K22D/ K52D/ R63D 
D89R / D96R 
Positive - Negative - Neutral *Not Done 
Table 2. Residues mutated according to mutation type and groove location. 
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NC wt D89R D96R D118R E26R 
Figure 10. Representative Gel of Alkaline Cleavage assay. 
] Substrate 
] Deamination 
Product 
AID enzyme was incubated with radioactively labelled substrate at 37°0 followed by subsequent 
37°0 incubations with UDG, NaOH and with denaturing dye. The DNA substrate and deamination 
product were electrophoretically resolved on denaturing gels and imaged using a phosphoimager. NC 
= negative control of substrate without AID enzyme, wt =wild type AID as a positive control. Each 
mutation label indicates the AID enzyme with the corresponding mutation. 
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K52A 
(sub] (JM) 25 20 15 10 7.5 5 2.5 1.25 0.625 0.313 0.156 NC 
] Substrate 
] Deamination Product 
Figure 11. Representative gel image of Alkaline Cleavage Kinetic assay for K52A AID 
mutant. 
Varying amounts (0.156- 25 JM) of purified AID enzyme were incubated with radioactively labelled 
substrate at 37 oc followed by subsequent 37°0 incubations with UDG, NaOH and with denaturing 
dye. The DNA substrate and deamination products were electrophoretically resolved on denaturing 
gels and imaged using a phosphoimager. NC = negative control of substrate without AID enzyme, wt = 
wild type AID as a positive control. 
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NC sl wt KS2D RSOD R63D 
Bound Substrate 
Free Substrate 
Figure 12. Representative gel image of EMSA Assay for three AID mutants (KS2D, RSOD 
and R63D). 
AID enzymes were incubated with radioactively labelled substrate at 37°0 then UV-crosslinked to 
preserve the AID:Substrate complex. Bound and unbound substrates were electrophoretically 
resolved on native gels and imaged using a phosphoimager. NC = negative control of substrate with 
no AID enzyme, sl =short linker wtAID and wtAID are positive controls. Each mutation label indicates 
the AID enzyme with the corresponding mutation. 
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R63A 
[sub] (jM) 25 20 15 10 7.5 5 2.5 1.25 0.625 0.313 0.156 
] Bound Substrate 
Free Substrate 
Figure 13. Representative gel image of kinetic EMSA Assay for R63A. 
Varying amounts (0.156- 25 JM) of purified AID enzyme were incubated with radioactively labelled 
substrate at 37°0 then UV-crosslinked to preserve the AID:Substrate complex. Bound and unbound 
substrates were electrophoretically resolved on native gels and imaged using a phosphoimager. The 
DNA substrate and deamination product were electrophoretically resolved on denaturing gels and 
imaged using a phosphoimager. 
49 
a. Groove 1: Mutants compared to wild-type using percentage of product formed 
-
(J 
20 
15 
::J , 
0 10 
~ 
~ 
~ 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
Mutant 
b. Groove 2: Mutants compared to wild-type using percentage product formed 
50 
40 
-(J 30 
::J , 
0 
~ 
~ 
~ 20 
0 
10 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
Figure 14. Alkaline Cleavage assay bar graphs for mutants in (a.) Groove 1 and (b.) 
Groove 2 
Graph represents average percent product of repeated Alkaline Cleavage experiments for each 
indicated mutant AID. SEM is indicated by error bars. 
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Figure 15. EMSA Binding Bar Graph 
Graph represents average percent bound substrate of repeated EMSA binding experiments for each 
indicated mutant AID. SEM indicated by error bars. 
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3.2.1 Groove 1: K22 results 
K22 is found within putative Groove 1 and is part of the NLS (Fig. 7, Fig. 16a). 
A substantial decrease in AID enzymatic activity occurred with mutations at residue 
K22; overall activity was reduced to 5 °/o for K22D, when compared to wt enzyme 
that generated 12 o/o deamination product under defined assay conditions (Fig. 14a). 
The K22A mutation was a less drastic change in residue charge but still led to a 
reduced AID activity, with approximately 3.5 °/o deamination product formed under 
similar assay conditions (Fig. 14a). The K22D mutation caused a decrease in activity 
according to kinetic curves, coincident with a decrease in Km to 5.313 x 10-4 nM from 
3.824 nM for wt AID (Fig. 16, Table 3). K22A demonstrated a decrease in enzyme 
efficiency, with a Km value of 10.36 nM (Fig. 16, Table 3). 
Changes in mutant AID activity may be influenced by the duration of ssDNA 
substrate binding. An increase in the percentage of bound ssDNA was evident for 
K22D over wt AID, with~ 3 °/o bound product compared to~ 1.5 °/o, respectively (Fig. 
1Sa). K22A bound-complex was much less than wt, at~ 0.5 °/o (Fig. 15a). In terms of 
dissociation constants, Kct for K22D increased to 0.2864 nM, relative to 0.1137 nM 
for wt AID, indicating an overall decrease in binding affinity (Fig. 16e, Table 3). 
K22A exhibited very similar ssDNA substrate binding affinity to wt AID, with a 
similar Kd value of 0.1204 nM (Fig. 16f, Table 3). 
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Figure 16. Groove 1: K22 mutations and assays 
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Purified AID was assayed for enzymatic reaction velocity and for substrate binding affinity 
against a single-stranded DNA substrate in its native sequence (wt) or following the 
introduction of single or combination amino acid mutations in Groove 1 (a.) or Groove 2 (b.) 
of the enzyme. Velocity (c. and d.) and binding affinity (e. and f.) of K22D and K22A, 
respectively, relative to wt. Data represents three independent assays. Km and Kd values 
were calculated from data plots in-software using non-linear regression. 
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3.2.2 Groove 1 and 2: R24 results 
The R24 residue is located in an overlap between Groove 1 and 2 and thus 
must be considered as evidence for both Grooves as a potential docking site of AID 
substrate (Fig. 17 a, & b). R24 also lies within the NLS domain of AID (Fig. 7). The 
mutations of R24 were nearly enzymatically dead compared to wt enzyme activity, 
the only mutation of Groove 2 to decrease activity. The activity of R24A and R24D 
produced less than 5 °/o deamination product versus 12o/o of product formed for wt 
(Fig. 14a). Due to such a great loss in activity, no kinetic velocity experiments were 
performed on R24 mutant enzymes. 
The decrease in activity may be due to an increased in substrate binding time. 
R24Ayielded an increase of bound ssDNA product with --3 % (Fig. 1Sa) compared 
to 1.5 o/o that of wt AID, an approximate 2-fold increase. R24D exhibited one of the 
most significant increases in binding, with 14 °/o product versus --1.5 o/o of wt, an 
approximate 9-fold increase. Binding kinetics for these R24A and R24D resulted in 
lower dissociation constants of 0.01856 nM and 0.02854 nM respectively, indicating 
increased binding affinity over wt with a Kd value of 0.1204 nM (Fig. 17c & d, Table 
3). 
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Figure 17. Groove 1 & 2: R24 mutations and assays 
Purified AID was assayed for substrate binding affinity against a single-stranded DNA 
substrate in its native sequence (wt) or following the introduction of single or combination 
amino acid mutations in Groove 1 (a.) or Groove 2 (b) of the enzyme. Binding affinity of 
R24D and R24A (relative to wt). Binding affinity (c. and d.) of R24D and R24A, respectively, 
relative to wt. Data represents three independent assays. Kd values were calculated from 
data plots in-software using non-linear regression. 
55 
3 
3.2.3 Groove 1 and 2: R25 Results 
R25 is found in both Groove 1 and Groove 2 and must be considered as 
evidence for both grooves (Fig. 18a). A significant decrease in enzyme activity was 
found for both R2SD and R25A mutants. Each mutant enzyme formed approximately 
1.5 °/o one tenth of the product which wt formed (Fig. 14a ). Since little activity was 
shown, velocity experiments were not performed for either R25 mutant. 
Compared to the binding results of wt AID, R2SD exhibited similar binding, 
with --2 °/o of bound substrate formed. R25A showed a decrease in bound product, 
yielding approximately half of bound substrate wt AID binds (Fig. 15a). Binding 
affinity constant Kd of0.02131 nM (Fig. 18, Table 3) for R2SD demonstrated a 5-fold 
increase in affinity for substrate in comparison to the wt values of 0.113 7 nM. R2 SA 
had a slight increase in binding affinity with Kd of 0.1041 nM (Fig. 18c & d, Table 3). 
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Figure 18. Groove 1: R25 mutations and assays 
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Purified AID was assayed for substrate binding affinity against a single-stranded DNA 
substrate in its native sequence (wt) or following the introduction of single or combination 
amino acid mutations in Groove 1 (a.) or Groove 2 (b.) of the enzyme. Binding affinity of 
R25D (c.) and R25A (d.), relative to wt. Data represents three independent assays. Kd values 
were calculated from data plots in-software using non-linear regression. 
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3.2.4 Groove 1: R63 results 
R63 is found within Groove 1 of the AID surface and within the cytidine 
deaminase domain of the sequence (Fig. 19 a). The R63D mutation resulted in 
approximately one-third reduction of activity, forming 8 o/o product compared to 
12 o/o for wt AID (Fig. 14a). However, R63A showed an increase in product formed 
with 17 %, an approximate 1.5-fold increase (Fig. 14a). The enzyme velocity 
experiments were contrary to the activity assay results. Both R63D and R63A 
showed Km values exponentially higher than that of wt, 1.344 x 10+15, 1.28e x 10+14 
and 3.824 nM, respectively (Fig. 19c & d, Table 3). This suggests a highly significant 
decrease in reaction velocity for R63D and R63A. 
The binding assay for R63D displayed a 4-fold increase of bound substrate 
from approximately 1.5% bound for wt to 6% for R63D (Fig. 15a). Likewise, the 
binding affinity calculated for R63D from kinetic experiments, Kd 0.08846 nM was 
one order of magnitude smaller than that ofwt, 0.1137 nM, indicating a greater 
binding affinity (Fig. 19e, Table 3). R63A displayed a 2-fold increase with 4 %bound 
substrate over 1.5 °/o bound by wt (Fig. 15a). Contrary to this result, kinetic 
experiments elucidated a Kd value of 0.3873 nM an approximate 3-fold increase of 
that of wt indicating an increase in binding affinity for R63A (Fig. 19f, Table 3). 
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Figure 19. Groove 1: R63 mutations and assays 
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Purified AID was assayed for enzymatic reaction velocity and for substrate binding affinity 
against a single-stranded DNA substrate in its native sequence (wt) or following the 
introduction of single or combination amino acid mutations in Groove 1 (a.) or Groove 2 (b) 
of the enzyme. Velocity and binding affinity of R63D (c. and e., respectively) and R63A (d. 
and f., respectively, relative to wt. Data represents three independent assays. Km and Kd 
values were calculated from data plots in-software using non-linear regression. 
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3.2.5 Groove 1: 089 results 
D89R showed a slight increase in enzyme activity with 14 °/o product formed 
versus 12 °/o produced by wt (Fig. 14a). The velocity for D89R increased to 0.4266 
over 3.824 nM ofwt, which demonstrated a reduced enzyme velocity (Fig. 20c, Table 
3). D89A, a neutral charge mutation, halved the activity of wt AID, producing only 
6 °/o of product (Fig. 14a). The calculated velocity for D89A opposes this reduction of 
activity with a decreased Km value of 5.141 compared to 3.824 nM ofwt (Fig. 20d, 
Table 3). This suggests an increase in enzyme velocity. 
The binding assays show little change in bound substrate for D89 mutations 
versus the substrate bound by wt AID. D89R produced 2 % of bound substrate and 
D89A, 1.5 o/o a slight increase and similar values respectively to wt bound substrate 
of 1.5 °/o (Fig. 15a). D89A also maintains a similar binding affinity of 0.1240 nM to wt, 
0.1137 nM with an approximate one-tenth increase, which indicates a reduction in 
binding activity (Fig. 20f, Table 3). On the contrary, the Kd of D89R is 0.4266 nM, an 
approximate 4-fold increase over the wt value, which is a significant decrease in 
binding affinity (Fig. 20e, Table 3). 
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Figure 20. Groove 1: 089 mutations and assays 
Purified AID was assayed for enzymatic reaction velocity and for substrate binding affinity 
against a single-stranded DNA substrate in its native sequence (wt) or following the 
introduction of single or combination amino acid mutations in Groove 1 (a.) or Groove 2 (b) 
of the enzyme. Velocity (c. and d.) and binding affinity (e. and f.) of D89R and D89A, relative 
to wt. Data represents three independent assays. Km and Kd values were calculated from 
data plots in-software using non-linear regression. 
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3.2.6 Groove 1: 096 results 
The enzymatic activity of D96R is comparable to that of wt, which resulted in 
11 °/o of product and 12 °/o of product, respectively (Fig. 14a). Despite the similarity 
in activity, the velocity determined for D96R, 2.145 nM, is just over half of that of wt 
at 3.824 nM, suggesting an increase in enzyme efficiency (Fig. 21c, Table 3). 
Binding assays for D96R and wt AID both resulted in 1.5 °/o of bound 
substrate indicating no significant change in binding (Fig. 15a). The Kd of D96R was 
calculated as 0.1664 nM, approximately one tenth ofwt Kd 0.1137 nM, which 
suggests a significant increase in binding affinity (Fig. 21d, Table 3). 
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Figure 21. Groove 1: 096 mutations and assays 
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Purified AID was assayed for enzymatic reaction velocity and for substrate binding affinity 
against a single-stranded DNA substrate in its native sequence (wt) or following the 
introduction of single or combination amino acid mutations in Groove 1 (a.) or Groove 2 (b) 
of the enzyme. Velocity (c.) and binding affinity (d.) of D96R, relative to wt. Data represents 
three independent assays. Km and Kd values were calculated from data plots in-software 
using non-linear regression. 
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3.2.7 Groove 1: 0118 results 
The enzymatic activity of D118R showed a significant decrease to 4 °/o 
product approximately one third of that ofwt at 12 °/o product (Fig. 14a). Coincident 
reduction was seen in enzyme velocity with an increased Km of 4.586 nM over 3.824 
nM of wt (Fig. 22c, Table 3). 
Binding of D118R was approximately 0 °/o, a significant decrease from wt 
bound product of 1.5% (Fig. 15a). The calculated Kd for D118R was -0.001209 nM, 2 
orders of magnitude smaller than wt, which indicates a stronger binding affinity for 
substrate (Fig. 22d, Table 3). 
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Figure 22. Groove 1: 0118 mutations and assays 
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Purified AID was assayed for enzymatic reaction velocity and for substrate binding affinity 
against a single-stranded DNA substrate in its native sequence (wt) or following the 
introduction of single or combination amino acid mutations in Groove 1 (a.) or Groove 2 (b) 
of the enzyme. Velocity (c.) and binding affinity (d.) of D118R, relative to wt. Data represents 
three independent assays. Km and Kd values were calculated from data plots in-software 
using non-linear regression. 
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3.3.1 Groove 2: E26 results 
The two mutations of residue E26 had opposing effects on enzyme activity. 
E26R produced approximately one sixth of the product relative to wt AID, a 
comparison of 2 °/o versus 12 °/o, respectively (Fig. 14b). The Km for E26R is in 
agreement with this result with a calculated value of 3.617 x 10+12 nM, a theoretical 
saturation level, indicating very low catalytic rate compared to the wt value of 3.824 
nM (Fig. 23c, Table 3). Conversely, E26A produced almost 2.5 times the amount of 
product of wt with a result of 30 %. Kinetic experiments yielded a Km value of 9.286 
x 10+18 nM, which like E26R represents a dramatic decrease in catalytic activity (Fig. 
23d, Table 3). 
Both E26R and E26A bound to less substrate with approximately 0.25 °/o and 
0.5 °/o, respectively versus 1.5 %substrate bound by wt (Fig. 15b ). Contrary to these 
binding results, the Kd values for E26R and E26A are 0.02070 nM and 0.01941 nM, 
similar values but also an order of magnitude smaller than that of wt at 0.113 7 nM 
(Fig. 23e & f, Table 3). These values indicate an increase in binding affinity of these 
mutant enzymes for ssDNA. 
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Figure 23. Groove 2: E26 mutations and assays 
Purified AID was assayed for enzymatic reaction velocity and for substrate binding affinity 
against a single-stranded DNA substrate in its native sequence (wt) or following the 
introduction of single or combination amino acid mutations in Groove 1 (a.) or Groove 2 (b) 
of the enzyme. Velocity (c. and d.) and binding affinity (e. and f.) ofE26R and E26A, relative 
to wt. Data represents three independent assays. Km and Kd values were calculated from 
data plots in-software using non-linear regression. 
67 
3.3.2 Groove 2: RSO results 
The enzymatic activity of R50D was also diminished with less than 1 % 
product in comparison to 12 o/o ofwt (Fig. 14b). Due to such little activity; no 
velocity was determined for this mutant enzyme. R50A similarly displayed a greatly 
reduced product, at 3 %, approximately one quarter that ofwt (Fig. 14b). R50A had 
a greatly reduced calculated enzyme velocity of 0.5615 nM, approximately one-
seventh that of wt, 3.824 nM indicating an increase in reaction velocity (Fig. 24c, 
Table 3). 
R50D also showed reduced bound substrate of 1 °/o versus 1.5 °/o of wt (Fig. 
15b ). However, kinetic experiments yielded a 10-fold reduced Kd value of 0.087 40 
nM compared to wt of 0.1137, suggesting an increased in binding affinity (Fig. 24e, 
Table 3). Opposing these results, R50A displayed an increase in bound substrate 
compared to wt, with 3 °/o over 1.5 °/o, respectively. Likewise, R50A displayed an 
increase in binding affinity with a ten-fold reduced Kd value from wt of 0.1137 to 
0.01755 nM of R50A (Fig. 24d, Table 3). 
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Figure 24. Groove 2: RSO mutations and assays 
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Purified AID was assayed for enzymatic reaction velocity and for substrate binding affinity 
against a single-stranded DNA substrate in its native sequence (wt) or following the 
introduction of single or combination amino acid mutations in Groove 1 (a.) or Groove 2 (b.) 
of the enzyme. Velocity ofRSOA (c.) and binding affinity ofRSOA (d.) and RSOD (e.), relative 
to wt. Data represents three independent assays. Km and Kd values were calculated from data 
plots in-software using non-linear regression. 
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3.3.3 Groove 2: KS2 results 
The enzymatic activity of K52D was reduced compared to wt with 1 and 12 °/o, 
• 
respectively, suggesting reduced enzyme activity (Fig. 14b). Contrary to these 
results, the determined Km for K52D was 1. 770 nM approximately half of the wt 
value at 3.824 nM indicating an increase in reaction velocity (Fig. 25c, Table 3). 
K52A displayed decreased substrate product, at 7 °/o just over half of that of wt of 
12% indicating decreased activity (Fig. 14b). Likewise, K52A had an exponentially 
higher calculated Km of 2.61 Oe+ 15 nM compared to wt of 3.824 nM indicating a great 
decrease in reaction velocity (Fig. 25d, Table 3). 
K52D showed increased bound substrate of 4 °/o versus 1.5 °/o of wt (Fig. 15b ). 
However, kinetic experiments yielded a similar Kd value of 0.1306 nM compared to 
wt of0.1137 nM, suggesting a slight decrease in binding affinity (Fig. 25c, Table 3). 
Opposing these results, K52A displayed a decrease in bound substrate compared to 
wt, with 1 °/o over 1.5 %, respectively (Fig. 15b). Likewise, K52A displayed a 
decrease in binding affinity with an exponentially increased Kd value from wt of 
0.1137 nM to 1.723 x 10+15 nM of K52A (Fig. 25, Table 3). 
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Figure 25. Groove 2: K52 mutations and assays 
0.03 
~ 
-.5 i 0.02 
0 
.s 
-~ 0.01 j 
- K52A 
~-wt 
Km = ~610 X 10+15 nM 
o.oo.-.:..,_-------------.... 
0 1 2 3 
[Substrate] (nM) 
0.8 
- K52A Kd = 1.723 x 1~+15 nM 
~-wt 
0.6 
-l 
~ 0.4 
~ 
m 
0.2 
0.0 
0 1 2 3 
Free (nm) 
Purified AID was assayed for enzymatic reaction velocity and for substrate binding affinity 
against a single-stranded DNA substrate in its native sequence (wt) or following the 
introduction of single or combination amino acid mutations in Groove 1 (a.) or Groove 2 (b) 
of the enzyme. Velocity (c. and d.) and binding affinity (e. and f.) of KS2 D and KS2A, relative 
to wt. Data represents three independent assays. Km and Kd values were calculated from 
data plots in-software using non-linear regression. 
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3.4.1 Multiple Mutants: K22D/K52D, K22D/R63D AND K22D/K52D/R63D 
K22D/K52D and K22D/K52D/R63D have mutations along Grooves 1 and 2 
while K22D/R63D has mutations solely in Groove 1. K22D/K52D, K22D/R63D and 
K22D/K52D/R63D showed no enzyme activity with approximately 0 °/o product 
formed during Alkaline Cleavage Assays compared to 12 °/o produced by wt (Fig. 
14b). Due to lack of activity, no kinetics were run for these mutant enzymes and 
therefor no Km values were determined. 
A variety of results were found for binding assays. K22D/K52D showed an 
approximate 5-fold increase in bound substrate with 8 %versus 1.5 % of wt (Fig. 
15b ). Contrary to this results, kinetic binding experiments yielded a slight increase 
in Kd value compared to wt with 0.1654 nM and 0.1137 nM, respectively, indicating a 
slight decrease in binding affinity (Fig. 26c, Table 3). K22D /R63D yielded the same 
amount of bound substrate as wt with 1.5 °/o (Fig. 15b) for each. The Kd of 
K22D/R63D, however, was an order of magnitude smaller than that ofwt, with 
0.016883 nM compared to 0.1137 nM (Fig. 26d, Table 3). This corresponds with the 
decrease in Kd value but the K22D/R63D mutation yielded a significantly smaller 
value of 0.007286 nM compared to 0.1137 nM ofwt, indicating a far high binding 
affinity for AID substrate (Fig. 26e, Table 3). 
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Figure 26. Groove 1 and 2: Multiple Mutant K22D/K52D/R63D assays 
Purified AID was assayed for substrate binding affinity against a single-stranded DNA 
substrate in its native sequence (wt) or following the introduction of single or combination 
amino acid mutations in Groove 1 (a.) or Groove 2 (b.) of the enzyme. Binding affinity of 
K22D/K52D (c.), K22D/R63D (d.), and K22D/K52D/R63D (e.), relative to wt. Data 
represents three independent assays. Kd values were calculated from data plots in-software 
using non-linear regression. 
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3.4.2 Multiple mutants: R24D/R63D and R25D/R63D results 
R25D/R63D and R24D/R63D although containing similar mutation yielded 
different results. Their activity values were respectively and approximately 0.5 °/o 
and 0 °/o product compared to 12 °/o ofwt (Fig. 14b). Considered enzymatically dead, 
these mutants were not tested kinetically and have no calculated Km values. 
Binding experiments showed that R25D /R63D had an approximate 9-fold 
increase in bound product with 14 °/o compared to wt with 1.5% and R24D/R63D 
showed an approximate 5-fold increase with 8% (Fig. 15b). The Kd found for 
R25D/R63D does not correspond to an increase in binding, as it is far greater than 
wt of0.1137 nM at 6.573 nM indicating a far smaller binding affinity for substrate 
than wt (Fig. 27d, Table 3). R24D/R63D resulted in a significantly smaller Kd value of 
0.003794 nM compared to wt of0.1137 nM suggesting a far higher binding affinity 
compared to wt (Fig. 27e, Table 3). 
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Figure 27. Groove 1 and 2: Multiple Mutant R24D/R63D 
Purified AID was assayed for substrate binding affinity against a single-stranded DNA 
substrate in its native sequence (wt) or following the introduction of single or combination 
amino acid mutations in Groove 1 (a.) or Groove 2 (b.) of the enzyme. Binding affinity of 
R24D/R63D (c.) and R25D/R63D (d.), relative to wt. Data represents three independent 
assays. Kd values were calculated from data plots in-software using non-linear regression. 
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3 
3.4.3 Multiple Mutants: D89R/D96R 
The product yielded from D89R/D96R is approximately one sixth of that 
yielded from wt, 2 and 12% respectively (Fig. 14b). This is consistent with the 
larger Km value found for D89R/D96R of 7.799 nM versus 3.824 nM found for wt (Fig. 
28b, Table 3). 
In terms of bound substrate, D89R/D96R bound 1.5 o/o of substrate, 
equivalent to wt (Fig. 15b ). Despite these values, D89R/D96R had an exponentially 
higher Kd compared to wt with 5.875 x 10+13 nM and 0.1137 nM respectively (Fig. 
28c, Table 3). This suggests that the double mutation D89R/D96R has an 
exceptionally low binding affinity for ssDNA. 
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Figure 28. Groove 1: Multiple Mutant D89R/D96R assays 
Purified AID was assayed for substrate binding affinity against a single-stranded DNA 
substrate in its native sequence (wt) or following the introduction of single or combination 
amino acid mutations in Groove 1 (a.) or Groove 2 (b.) of the enzyme. Velocity (c.) binding 
affinity (d.) of D89R/D96R, relative to wt. Data represents three independent assays. Kd 
values were calculated from data plots in-software using non-linear regression. 
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3.5 Mutation Summary 
In terms of activity, Groove 1 mutations yielded two that increased activity 
and enzymatic velocities, R63A and D89R. Eight mutations decreased activity to 
such an extent that no kinetics were performed and samples were deemed 
enzymatically dead: R24D, R25A, R2SD, double mutants R24D /R63D, R2SD /R63D, 
K22D/KS2D, K22D/R63D, and the triple mutant K22D/KS2D/R63D. The following 
mutations were consistent in their results of decreasing enzymatic activity and 
kinetics, including calculated Michaelis constants (Vm): K22D, K22A, R24A, RSOA, 
KS2D, D96R, D118R, and double mutant D89R/D96R. Of special note were some 
mutations, which produced inconsistent results, including D96R- although this 
mutation showed decreased deamination activity and kinetics, the V m for this 
enzyme was actually higher than wt AID. D89A showed a decrease in general activity, 
but an increase in both catalytic activity and Vm. R63D, however, showed an increase 
in general activity but a decrease in catalytic activity and a decrease in V m. 
For Groove 2, RSOD was deemed enzymatically dead. RSOA and K52D were 
both consistent with decreased activity, kinetic, and Vm results. K52A, however, 
showed a decrease in activity but an increase in enzymatic velocity and V m results. 
E26R and E26A produced very inconsistent results. E26R decreased activity, 
increased enzymatic velocity, and decreased V m· E26A, however, increased activity, 
decreased enzymatic velocity, and yet increased V m. 
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The majority of mutations showed consistent results in terms of binding and 
subsequent kinetic experiments. From Groove 1, K22D, R24D, R24A, K2D/KS2D, 
K22D/K52D/R63D, R24D/R63D, R2SD/R63D, R63D, R63A, and D89R were all 
consistent in increasing binding to ssDNA substrate in EMSA and kinetic assays. 
R2SD, D89A, D96R, K22D/R63D, and D89R/D96R also increased AID substrate 
binding; but marginally- their bound substrate levels were comparable to wt AID. 
These all showed increased binding kinetics. D118R showed a decreased in bound 
substrate that was reflected in its kinetic experiments. 
From mutations within Groove 1, K22A and R25A showed inconsistent 
results. They both decreased binding in the standard assay, yet their kinetics 
revealed a higher binding affinity. 
For Groove 2, RSOA and KS2D showed an increase in binding in the standard 
and kinetic assays. Inconsistent results for E26R, E26A, RSOD, and K52A were 
apparent. They all showed a decrease in substrate binding, however, they all showed 
an increase in their kinetic assays. It is of note that E26R and E26A also showed 
inconsistent results for deamination activity assays. 
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Mutant 
wild-type 
K22D 
K22A 
R24D 
R24A 
R25D 
R25A 
R63 D 
R63A 
D89R 
D89A 
D96R 
D118R 
E26R 
E26A 
RSOD 
RSOA 
K52D 
KS2A 
K22D/ K52D 
K22D/ R63D 
R24D/ R63D 
R2SD/ R63D 
K22D/ K52D/ R63D 
D89R / D96R 
Michaelis Constant, 
Km (nM) 
3.824 
5.313e-4 
10.36 
1.344e+15 
1.378e+14 
2.486e+19 
5.141 
2.145 
4.586 
3.617e+12 
9.286e+18 
0.5615 
1.770 
2.610e+15 
7.799 
Table 3. Enzyme Kinetics constant Values 
Dissociation Constant, 
Kd (nM) 
0.1137 
0.2864 
0.1204 
2.854e-2 
1.856e-2 
2.131e-2 
0.1041 
8.846e-2 
0.3873 
0.4266 
0.1240 
1.664e-2 
-1.209e-3 
2.070e-2 
1.941e-2 
8.740e-2 
1.755e-2 
0.1306 
1.723e+015 
0.1654 
1.688e-2 
3.794e-3 
6.573 
7.286e-3 
5.875e+13 
Constants were calculated based on data from kinetic experiments using in software 
functions. Repeated experiments had data combined. 
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Chapter 4 Discussion 
To compare the effects of mutations generated within the enzyme on its 
activity as well as substrate binding, all experiments were also performed using 
human wt GST -AID. The Km, and dissociation constant, Kd, were determined for wt 
AID. The generated kinetic curves and constants were used as a baseline for 
comparison. Some mutants were found to have significant deamination activity, and 
were tested kinetically, whereas all mutants underwent kinetic binding studies. The 
kinetic constants inversely reflect the behaviour they represent; a larger Km value 
indicates a decrease in enzyme efficiency, while a larger Kd value demonstrates a 
decreased binding ability in comparison to the wt values. 
4.1 Alkaline Cleavage and EMSA 
For mutants with measurable kinetic activity and substrate binding, the 
individual alterations in the overall levels of deaminated and bound products were 
not always consistent with kinetic data used to determine Km and Kd. One possible 
explanation could be the nature of the experimental strategy, where the means were 
based on 2-4 individual reactions at a fixed substrate concentration. The kinetic 
experiments involved 11 reactions over a wide range of substrate concentrations, 
with reactions at low substrate concentrations being crucial for constant 
determinations. Trends based on these experiments are more accurate than single 
concentration assays, as they include multiple data points; however, it should be 
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noted that some of the most altered Km and Kd values at the extreme high and low 
ranges are only estimates, because the enzyme activities were affected by mutations 
to such an extent that saturation of activity or binding could not be reached at higher 
concentrations. 
4.1.1 Groove 1 Mutations 
Mutation at residue 22 from positive lysine to aspartic acid (K22D) caused a 
decrease in Km as shown in Table 3. Such a large decrease of the Michaelis constant 
from that of wt AID indicates higher enzymatic efficiency. This disagrees with our 
original hypothesis that the negatively charged arginine would repel rather than 
attract negatively charged single-stranded DNA, leading to lower enzyme activity, 
rather than an increase. This suggests that the charge of residue 22 is less important 
for activity than other residues, and that the observed changes in behaviour could be 
due to conformation changes within the protein itself. As well, the mutations lead to 
a lower binding affinity but this corresponded with an increase in enzyme activity. A 
mutation to a charge-neutral residue, alanine (K22A), had a lesser affect on activity 
as seen in Figure 16. The Km increased, indicating lower enzyme efficiency. This 
suggests that the positive charge of lysine does play a role, albeit a minor one, in 
activity since a neutral mutation reduces enzyme efficiency. 
Two other mutated residues located close to K22 were R24D and R24A, both 
of which appeared to be enzymatically inactive. Following our hypothesis, this could 
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be due to the loss in overall positive charge along the putative binding grooves from 
either mutation. Whilst the R24D drastic mutation could alter the overall folding of 
AID, this is far less likely for the R24A mutation. Therefore, the detrimental effect of 
these mutations on activity suggests that R24 is important for activity. For binding, 
both mutations show an overall trend of significantly increased bound substrate. 
This is further supported by EMSA kinetics where their Kd values were reduced by 
more than 10 fold, representing a large increase in binding ability due to R24D and 
R24A mutations. These effects may be due to conformational changes within the 
groove (Fig. 29). Although these results are counterintuitive, in that a positive to 
negative or neutral residue substitution was predicted to decrease DNA binding 
affinity, they suggest that R24 is somehow involved in DNA binding. Additionally, 
the vast increase in binding affinity may explain the drastic decrease in enzymatic 
activity, as the enzyme is unable to release a substrate in order to bind the next 
substrate molecule. 
Both R2SD and R2SA appeared to be enzymatically inactive. Here, the change 
to a negative residue caused a more drastic increase in binding than when a neutral 
amino acid is substituted into the protein. Like the case with R24, this result is the 
opposite of what we would expect given our hypothesis; therefore, it appears that 
charge is not the primary component in AID behaviour. This suggests that R2 5 is 
also involved in ssDNA binding. As was the case with R24, this result further 
suggests that activity and binding are not completely interdependent, as some of our 
mutations exerted opposing affects on these two enzymatic properties. 
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Wild-type AID R24D AID R24A 
Figure 29. Models of R24 in wild-type AID, R24D mutation and R24A mutation. 
Models were generated using rrmol software. 
Blue= Positive, Red= Negative, White= Neutral, Purple= Catalytic Pocket 
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The R63A mutation, which resulted in an extremely high Km and little enzyme 
activity, did not produce kinetic values as low as R63D. Binding for R63D showed a 
decrease in Kd, indicating an increase in binding efficiency. R63A however, shows 
more than a 3 times increase in Kd compared to wt, indicating a decrease in binding 
efficiency. This indicates that the positive charge of R63 may be important for 
ssDNA binding, but that the drastic R63D mutation caused a four-fold change. 
Overall, this data suggests R63 is important for AID activity and for binding, based 
on the change in kinetic coefficients. 
R63A is a positive to neutral mutation that resulted in an increase in Km, 
indicating that the enzyme was rendered less efficient. If the charge of this amino 
acid is involved in AID activity, the conversion to a neutrally charged residue should 
decrease activity with negatively charged substrate DNA, which was the observation. 
Conversion of positive R to a negatively charged residue D rendered AID 
enzymatically dead, further supporting the involvement of R63 and its positive 
charge with ssDNA. 
Following our hypothesis, a negative to positive or neutral residue mutation 
would result in an increase in product formation. This was observed for mutants 
D89R and D89A, both of which resulted in an increase in deamination, D89R more 
so than D89A. D89R is a negative to positive mutation that increased activity. This is 
likely due to the increase in overall positive charge within the groove, which would 
more strongly attract and bind negatively charged single-stranded DNA. According 
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to alkaline cleavage kinetic constants, both D89R and D89A increased compared to 
wt AID, suggesting a paradoxical decrease in enzyme efficiency. D89R's Km value 
increased exponentially, indicating an extreme decrease in enzyme efficiency. Both 
mutants also showed increased Kd values, indicative of a lower ssDNA binding 
affinity. Therefore, the negative charge of these two residues does not seem to repel 
ssDNA, and they are likely not positioned along the ssDNA binding site of AID. 
The D96R mutation also results in a decreased Km to just over half that of the 
wt. This decrease suggests higher enzyme efficiency over wt AID. In this case, the 
change from negative to positive charge can explain the increase in activity, as the 
negatively charged DNA would be more highly attracted to the positively charged R 
rather than the negatively charged D originally in its place. This is further supported 
by the decrease in dissociation constant by approximately 10-fold, interpreted as 
increased binding. The results suggest that D96 may be positioned close to the 
ssDNA binding groove. 
The D118R mutation led to an increased estimated Km, implying a decrease in 
enzyme efficiency compared to wt, correlating to the decrease in velocity as seen in 
the kinetic curve. This is unexpected, as the mutation to a positive residue 
theoretically would have increased activity. One interpretation is that D118 may not 
be directly involved in AID:substrate association. The estimated Kd was also vastly 
reduced, indicating a much higher binding affinity. Overall, D118R appears to 
decrease deamination and increase binding. This is possible if the enzyme binds to 
86 
the substrate for a much longer period of time, reducing the overall amount of 
deamination. 
4.1.2 Groove 2 Mutations 
The next residue tested for activity kinetically was E26. Mutation to a positive 
residue, arginine, shows an increase in enzyme activity by the gross amount of 
product generated, but an increased Km (Fig. 23). Such an increase implies lower 
enzyme efficiency due to the charge disruption; thus, E26 appears to be important 
for activity. Mutation of the same residue to neutral-charged alanine produces a 
similar effect to Km, which agrees with the role of E26 in velocity. As shown in Figure 
23, the kinetic curve shows an overall decrease in velocity. It can be said that 
disrupting the negative charge hampers AID activity, suggesting that this residue is 
involved in AID activity through an unknown mechanism. Since this is a negatively 
charged residue, contact with the phosphate backbone of ssDNA may be a possibility. 
In terms of binding, E26R lowered the Kd, translating to an increase in binding ability, 
which may be due to the positive charge of arginine attracting negatively charged 
ssDNA. E26A slightly increased the Kd value and lowered binding ability, meaning 
that E26 is involved in AID activity and might be a factor in binding. 
RSOD also appeared to be enzymatically inactive in the activity assay; 
however, it caused a 10-fold decrease in Kd value. This result may imply that this 
mutant alters the overall folding of the enzyme. RSOA resulted in a Km value that was 
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15% that ofwt AID, indicating increased enzyme efficiency. This suggests that the 
electrostatic attraction of this residue and ssDNA is not important for AID activity. 
Rather, a change in the size and/ or shape of the binding groove could change 
efficiency of deamination. In terms of binding, the Kd was reduced even more than 
RSOD, also indicating an increase in binding efficiency of AID due to this mutation. 
This outcome supports the idea that charge may be a less important factor than size 
for maintaining the integrity of the putative ssDNA binding groove. 
Overall, the unexpected results for many of these mutations may be explained 
through size and distortion of the suggested binding grooves, rather than through 
electrostatic forces alone. Alternatively, the fact that many of these mutations from 
positively charged to negatively charged residues actually enhanced the binding of 
ssDNA, may indicate that these residues are not involved in direct contact with 
ssDNA, or that they are involved in ssDNA binding in an indirect and more complex 
manner, where the change to a negative residue may cause the attraction and 
change in conformation of a nearby positive residue "into" the putative groove, 
thereby mediating the overall mutation effects. 
KS2D is another mutation that increased AID deamination efficiency based 
on a decrease in Km. ssDNA binding kinetics revealed a dissociation constant with an 
approximate 20-fold increase over that of wt. This suggests that binding ability is 
decreased, so KS2 in its natural state is important for binding, whether due to charge 
or to conformation. Insight into the role of charge for this residue is evident with the 
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K52A mutation. Here, activity was eradicated and the mutation reduced binding 
even further with a higher order magnitude Kd value. From this, we can gather that 
this residue may be involved in direct or near direct contact with ssDNA. R63D was 
the next amino acid for mutation analysis, and it was also found to be enzymatically 
inactive, and thus initially indicated that both the residue identity and position were 
important for AID activity. 
4.1.3 Multiple Mutants 
K22D/KS2D showed little or no enzyme activity. Binding experiments 
showed similar results to that of wt; the overall curve trend of reaction velocity 
shows an increase in binding, but the Kd is slightly above that of wt AID, which 
means it is slightly more effective at substrate binding. 
The K22D/R63D multiple mutant showed no deamination activity, with no 
rescue of enzyme activity by K22D for R63D. This suggests that R63D has a more 
significant role in AID activity than K22D. When substrate binding was assayed, the 
resulting Kd value was about one tenth that of wt, indicating that a much greater 
binding efficiency was achieved. This value is smaller than either R63D or K22D, the 
latter of which increased Kd compared to wt, thus it had a compounded effect. 
K22D /KS2D /R63D, the only triple mutant, was also enzymatically dead. 
K22D and KS2D mutations cannot alleviate the loss of activity brought on by R63D. 
This could suggest that R63D is more crucial to deamination activity than either 
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K22D or KS2D. Binding kinetics reveal a dissociation constant about half that of 
K22D/R63D, and 1/SOth ofK22D/K52D. Ergo, the triple mutant appears to greatly 
enhance binding ability over either of its constituent mutations. 
R24D /R63D also showed no deamination activity, which was expected given 
that both mutations showed no AID activity. This can be explained by the loss of 
positively charged residues or possibly substrate contact site distortion. Binding 
experiments showed that this is the second smallest Kd value of all mutations 
assayed. This double mutation led to increased binding efficiency relative to wt AID, 
more so than either of its constituent mutations, which verifies their importance in 
AID binding. 
R25D /R63D, similar to other AID enzymes containing multiple mutations, 
showed no deamination activity. As the charges of the amino acids were converted 
from positive to negative, repulsion to substrate ssDNA can account for this lack of 
activity. Likewise, EMSA kinetics experiments resulted in a Kd value about a 60-fold 
increase over wt, showing a greatly reduced substrate binding efficiency. This was 
an unexpected result, as both of the mutations individually increased the binding 
affinity; thus, it was expected that the combination would compound the increase in 
substrate affinity. The reduction in activity and binding was most likely due to 
conformational changes to the putative binding grooves, AID protein folding, or a 
combination of both. 
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D89R/D96R mutation showed an increased Km suggesting a decrease in 
enzyme efficiency. The Kd value increased on the order of 1013, indicating almost 
complete ablation of ssDNA binding. This is fitting, since little activity resulted from 
this double mutation. From this evidence, we can gather that D89 is more involved 
in activity than D96. In terms of binding kinetics, the multiple mutant enzyme also 
has a higher Kd value, indicating that the D96R mutation is unable to rescue the 
drastic effect of the D89R mutation. Therefore, it is likely that D89 is more involved 
in the overall structural integrity of the protein while D96 plays a more direct role in 
ssDNA binding. 
4.2 The relationship between catalytic activity and ssDNA binding affinity of AID 
By comparing activity and affinity data, correlation between the two can be 
evaluated. A model emerges where there exists an optimal enzyme-substrate 
affinity zone in which the typical levels of AID activity can be achieved as substrate 
affinity and catalytic activity are balanced. Below this threshold, enzymes would 
have a very low affinity that results in lower activity. Likewise, there would exist an 
affinity threshold for optimal activity. If bound in the enzyme:substrate complex too 
long, the overall AID activity would decrease reducing the potential to deaminate 
multiple substrate targets (Fig. 30). 
The results of our experiments are highly suggestive of such a model, with 
the optimal zone of moderate enzymatic catalytic activity and binding affinity 
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assigned to wt AID levels (Fig. 30). Similar profiles were observed for K52D, D96R, 
and D89A mutations, which display activity and binding kinetics like wt AID. Mutant 
AID proteins that fall below the optimal affinity threshold with either low catalytic 
or high catalytic activity included: D118R, K22A, R63A, R63A, D89R, K22D/K52D, 
R2SD/R63D. Also included in this group was K22D, that exhibited very high 
enzymatic activity and low binding affinity. 
The last category includes mutant enzymes that displayed low catalytic 
activity, presumably due to overly high substrate binding affinities, such that 
enzyme turnover rates were too slow to permit high AID activity. This category was 
the largest grouping, suggesting these amino acid residues are the most sensitive to 
change and have great importance to AID binding affinity and activity. The 
mutations in this category included: D89R/D96R, E26R, R63D, K52A, E26A, 
R24D/R63D,K22D/K52D/R63D,K22D/R63D,R24A,R25D,R24D,RSOD,andR2SA. 
Interestingly, this group includes all types of residue switches, ranging from positive 
to negative, negative to positive, or charged to neutral residue changes. 
Overall, our data suggests that the binding mechanism of ssDNA by AID is 
easily disrupted by changes within its amino acid sequence and resulting structure. 
Subsequently, the enzyme can easily lose its optimal catalytic activity to binding 
affinity ratio. Based on the disruptions seen in activity and binding, Groove 1 
appears to be the most likely site for substrate interaction. 
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4.3 The role of AID surface structure in enzyme activity and binding 
The mutant enzymes had various levels of activity and binding compared to 
their wt counterpart. This suggests that both the charge and the size of amino acids 
can be imperative for AID and substrate interaction based on a delicate balance of 
residue shape and charge. Attractive forces would be required for substrate and 
enzyme interaction, while repulsion could act as a means to foster substrate 
turnover; reducing the time AID is involved in a protein: DNA complex. As seen in 
side-by-side structural modeling comparisons of wt R24, R24D, and R24A AID 
models (Fig. 29) the mutations can have dramatic effects, changing not only charge 
but also shape within the putative binding groove. This example shows a "tunnel-
like" effect that develops with the introduction of mutations at this residue, in 
addition to new charge and charge distribution. It is possible that the other 
mutations have also introduced a similar disruption in shape, which may explain the 
unexpected behaviour seen with some of the AID mutations. 
Of the twenty-four mutations induced within the AID sequence, only four 
increased activity efficiency: D96R, KS2D, RSOA, and K22D. Since three of these 
reduced the overall positive charge within the putative binding grooves, it can be 
said that the electrostatic interaction between residues and target ssDNA does not 
follow the hypothesis suggested. Positively charged residues do not always enhance 
activity with negatively charged substrate. A revised hypothesis suggests that other 
factors are responsible for AID activity and interaction. 
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Based on these results, the mutations that caused the greatest disruption to 
activity are the most likely residues involved in deamination. According to Km values, 
those residues are on either end of the spectrum: Km (largest to smallest) 
D89R>E26A>R63A>E26R>K22A>D89R/D96R>D89A>D118R>wt>D96R>K52D>R50 
A>K22D. Except for D96R, D118R, and D89A, the mutations drastically increased 
enzyme efficiency (2-fold or more) or decreased it (by half). Overall these 
experiments show that residues R24, R25, E26, R63, and D89, which best align with 
Groove 1 (Fig. 5), are highly involved in AID activity. 
All mutant enzymes were tested kinetically for binding. When listed 
according to dissociation constant, there is no trend between charged residues and 
binding ability. Kd (largest to smallest): 
K52A>D89R/D96R>R25D/R63A>K22D>E26A>K22D/K52D>D89A>K22A>wt>R25A 
>R63D>R50D>R24D>R25D>E26R>R24A>R50A>K22D/R63D>D96R>K22D/K52D/ 
R63D>R24D/R63D>Dl18R. That is, the proposed hypothesis does not hold t rue for 
all residues. Those mutations which most greatly affected binding were K52A, 
D89R/D96R, K22D/K52D/R63D, R24D/R63D, and D118R, which all increased 
binding efficiency. From this, the residues most actively involved in substrate 
binding appear to be: K22, R25, K52, R63, D89, D96, and D118. With the exception of 
K52, these amino acids support Groove 1 as a likely contact site within AID for 
binding. Introduction of mutations to K52 may disrupt overall protein folding or 
charge distribution along the protein surface, explaining why changes to this amino 
acid can be detrimental to AID binding function. 
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Generated models of mutant AIDs show drastic shape changes within the 
putative binding grooves as a result of mutations, which can explain some of the 
unexpected behaviours seen in our assays (Fig. 29). Certain residue changes 
resulted in loss of protrusions along the grooves. An unexpected change in activity 
can imply that a residue's role in AID activity is not charge-centred, based on our 
hypothesis that a positively charged residue in theory would attract negatively 
charged DNA. Rather, differences in activity can appear due to a conformational 
change within the binding groove. For instance, by molecular weight, arginine is 
174.2 gfmol versus alanine at 89.1 gfmol, the largest amino acid weight change of 
all the mutations. Decrease in size could allow more room, and thus greater 
accessibility, for ssDNA to ~~fit" and contort into the groove site. Additionally, a 
mutation may cause a lapse in protein folding, thus altering enzyme substrate 
interaction in this matter. Overall, our work suggests that the change in amino acid 
size, and thus the shape and size of the suggested binding grooves, may be a much 
more significant determinant of ssDNA binding and activity, than the change in the 
charge itself. 
Altogether, activity and binding of AID are not solely dependent on the charge 
distribution of surface residues; however our results do seem to implicate a higher 
number of residues along putative Groove 1, rather than putative Groove 2. Similar 
findings support the involvement of surface residues in substrate interactions, 
including a polynucleotide-binding region alike to APOBEC enzymes (Wang, 2009). 
Specific implicating residues are Rand K surface residues, R24 and residues 
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surrounding 0118 of AID such as A111, R112 and L113 (Mu, et al., 2012; Hu et al., 
2013; Doi et al., 2008), which align with our results. 
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4.4 Future Studies 
The results from these experiments shed some light on surface residues of 
AID that impact ssDNA binding, as well as on the complexity of the relationship 
between the enzymatic rates of AID and its ssDNA binding affinity. There are 
several areas that should be explored to better understand AID and these results. 
It is noteworthy that the range in size of amino acids mutated varies greatly. 
This in turn may explain some of the observed differences in activity and binding, in 
addition to charge/electrostatic interaction. From largest to smallest: lysine (K, 146 
gfmol), arginine (R, 17 4 gfmol), aspartic acid (D, 133.11 gfmol), glutamic acid (E, 
147.13 gfmol), and alanine (A, 89.10 gfmol). Because of this, further studies should 
include mutations that consider a charge to size ratio when selecting amino acids for 
mutagenesis. The shape of the binding site and the density of charge could offset 
attraction or repulsion to target DNA- which factor accounts for the changes seen in 
these experiments is unclear, and could be better resolved. For example, conversion 
of Glutamic acid or Aspartic acid to Lysine instead of Arginine would allow for a 
more reliable study of charge difference on AID activity. Glutamine is a likely 
candidate for conversion to another charge neutral residue closer in size. Since these 
amino acids are closer in size to the amino acids they are replacing, size and shape 
would be eliminated as a major factor for any differences in activity and binding 
exhibited, if the mutations do not cause any major protein folding errors. These 
would more likely be due to the altered charge rather than due to the altered size. 
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Finally, in terms of multiple mutations, there are other interesting scenarios 
to explore. Of the 24 mutations induced, 8 of them decreased deamination activity. 
Of special note are K22D, RSOA, and K52D all of which rendered AID nearly inactive. 
The significance of each of their roles in activity can be determined by combining 
these mutations with others that greatly increased binding. If the introduction of an 
active mutation rescues the activity of either of the "dead" mutants, then the new 
mutation can be said to have a more detrimental role in activity. If the activity is not 
rescued, the primary mutation has a more integral role in enzyme activity. 
Since charge does not always appear to affect activity or binding, the 
possibility of other contact sites should be explored more directly using various 
footprinting techniques. Although far more challenging technically (especially for a 
highly charged molecule such as AID), these assays would complement our 
mutagenesis approach and together paint a more accurate picture of residues 
directly involved in substrate binding. 
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